Back To Index << Back To Terminology

# Value Set eHDSISubstance 2025‑02‑18 12:29:00

This terminology is a snapshot as of 2026‑02‑11 10:48:51. Terminologies may evolve over time. If you need recent (dynamic) versions of this terminology, please retrieve it from the source.
Id | 1.3.6.1.4.1.12559.11.10.1.3.1.42.61 | Effective Date | 2025‑02‑18 12:29:00 Other versions this id: eHDSISubstance202602 - as of 2026‑02‑06 15:56:00 eHDSISubstance202505 - as of 2025‑05‑07 13:00:00 eHDSISubstance202401 - as of 2024‑01‑25 16:55:00 eHDSISubstance202305 - as of 2023‑05‑02 17:30:00 eHDSISubstance202301 - as of 2023‑01‑17 16:45:00 eHDSISubstance202206 - as of 2022‑06‑23 15:55:00 eHDSISubstance202204 - as of 2022‑04‑28 17:45:00
Status | Final | Version Label | 202502
Name | eHDSISubstance | Display Name | eHDSISubstance
Description | The Value Set is used to code the substances of medicine.
Source Code System | 2.16.840.1.113883.3.6905.2 - FHIR: urn:oid:2.16.840.1.113883.3.6905.2
Level/ Type | Code | Display Name | Code System
--- | --- | --- | ---
0‑L | 300000050539 | DTx-1252 | 2.16.840.1.113883.3.6905.2
0‑L | 300000040718 | SPL23-2 | 2.16.840.1.113883.3.6905.2
0‑L | 300000037069 | SPL84-23-1 | 2.16.840.1.113883.3.6905.2
0‑L | 300000054911 | Pasifolate exatecan ELU001 | 2.16.840.1.113883.3.6905.2
0‑L | 300000044609 | Cepadacursen sodium CIVI 007 sodium | 2.16.840.1.113883.3.6905.2
0‑L | 300000044624 | all-P-ambo-5'-O-(26-[(2-acetamido-2-deoxy-beta-D-galactopyranosyl)oxy]-11,14- bis({4-[2-(2-{2-[(2-acetamido-2-deoxy-beta-D-galactopyranosyl)oxy]ethoxy}ethoxy)ethoxy]acetamido}butyl)-1,10,13,16- tetraoxo-1-sulfanyl-2,18,21,24,26-pentaoxa-9,12,15-triaza-1λ5- phosphahexacosan-1-yl)-2'-O,4'C-methylene-P-thioadenylyl-(3'->5')-2'-O,4'Cmethylene-P-thioadenylyl-(3'->5')-2'-O,4'C-methylene-5-methyl-P-thiouridylyl- (3'->5')-2'-deoxy-P-thioguanylyl-(3'->5')-2'-deoxy-P-thiocytidylyl-(3'->5')-Pthiothymidylyl-(3'->5')-2'-deoxy-P-thioadenylyl-(3'->5')-2'-deoxy-P-thiocytidylyl- (3'->5')-2'-deoxy-P-thioadenylyl-(3'->5')-2'-deoxy-P-thioadenylyl-(3'->5')-2'- deoxy-P-thioadenylyl-(3'->5')-2'-deoxy-P-thioadenylyl-(3'->5')-2'-O,4'Cmethylene-P-thiocytidylyl-(3'->5')-2'-O,4'C-methylene-5-methyl-P-thiocytidylyl- (3'->5')-2'-O,4'C-methylene-5-methyl-P-thiocytidylyl-(3'->5')-2'-O,4'Cmethylene-P-thioadenosine | 2.16.840.1.113883.3.6905.2
0‑L | 300000052084 | RNA, ([1'-de(6-Amino-9H-purin-9-yl)]dA-(5'->5')-sp-Am-Cm-Gm-Gm-Gm-Am-Cm-Am-(2'-deoxy-2'-fluoro)G-(2'-deoxy-2'-fluoro)U-(2'-deoxy-2'-fluoro)A-Um-Um-Cm-Um-CmAm-Gm-Um-Im-Am-(3'->3')-sp-[1'-de(6-amino-9H-purin-9-yl)]dA), 3'-[O-[cis-4-[(3S,8S)-17-[[2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl]oxy]-3,8-bis[[[2-[2-[[2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl]oxy]ethoxy]ethyl]amino]carbonyl]-1,6,11-trioxo-15-oxa-2,7,12-triazaheptadec-1-yl]cyclohexyl] hydrogen phosphorothioate] sodium salt, complex with RNA (Um-sp-(2'-deoxy-2'-fluoro)C-spAm-sp-(2'-deoxy-2'-fluoro)C-Um-(2'-deoxy-2'-fluoro)G-Am-Gm-Am-Am-Um-(2'-deoxy2'-fluoro)A-Cm-(2'-deoxy-2'-fluoro)U-Gm-(2'-deoxy-2'-fluoro)U-Cm-(2'-deoxy-2'-fluoro)C-Cm-(2'-deoxy-2'-fluoro)G-sp-Um) sodium salt (1:23:1:20) | 2.16.840.1.113883.3.6905.2
0‑L | 300000033141 | (2R)-5-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(1S)-2-[2-[[[(2S,4R)-4-[[2-[(1R,3R)-1-acetyloxy-4-methyl-3-[3-methylbutanoyloxymethyl-[(2S,3S)-3-methyl-2-[[(2R)-1-methylpiperidine-2-carbonyl]amino]pentanoyl]amino]pentyl]-1,3-thiazole-4-carbonyl]amino]-5-(4-hydroxyphenyl)-2-methylpentanoyl]amino]carbamoyloxy]ethyldisulfanyl]-1-carboxyethyl]amino]-1,5-dioxo-5-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]pentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1,5-dioxo-5-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]pentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1,5-dioxo-5-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]pentan-2-yl]amino]-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]-5-oxopentanoic acid | 2.16.840.1.113883.3.6905.2
0‑L | 300000046108 | 2'-O, 4'-C-Methylene-P-thio-adenylyl-(3'->5')-2'-O, 4'-C-methylene-P-thioguanylyl-(3'->5')-2'-O, 4'-C-methylene-P-thio-adenylyl-(3'->5')-2'-deoxy-P-thioadenylyl-(3'->5')-2'-deoxy-P-thio-thymidylyl-(3'->5')-2'-deoxy-P-thio-guanylyl-(3'->5')-2'-deoxy-P-thio-guanylyl-(3'->5')-2'-deoxy-P-thio-cytidylyl-(3'->5')-2'-deoxy-P-thio-adenylyl-(3'->5')-2'-deoxy-P-thio-cytidylyl-(3'->5')-2'-deoxy-Pthio-adenylyl-(3'->5')-2'-deoxy-P-thio-thymidylyl-(3'->5')-2'-deoxy-P-thio-cytidylyl-(3'->5')-2'-deoxy-P-thio-thymidylyl-(3'->5')-2'-O, 4'-Cmethylene-5-methyl-P-thio-cytidylyl-(3'->5')-2'-O, 4'-C-methylene-5-methyl-Pthio-uridylyl-(3'->5')-2'-O, 4'-C-methylene-5-methyl-P-thio-uridylyl-(3'->5')-2'-O, 4'-C-methyleneguanosine heptadecasodium salt | 2.16.840.1.113883.3.6905.2
0‑L | 300000046107 | 2'-O, 4'-C-Methylene-P-thio-adenylyl-(3'->5')-2'-O, 4'-C-methylene-P-thioguanylyl-(3'->5')-2'-O, 4'-C-methylene-P-thio-adenylyl-(3'->5')-2'-deoxy-P-thioadenylyl-(3'->5')-2'-deoxy-P-thio-thymidylyl-(3'->5')-2'-deoxy-P-thio-guanylyl-(3'->5')-2'-deoxy-P-thio-guanylyl-(3'->5')-2'-deoxy-P-thio-cytidylyl-(3'->5')-2'-deoxy-P-thio-adenylyl-(3'->5')-2'-deoxy-P-thio-cytidylyl-(3'->5')-2'-deoxy-P-thio-adenylyl-(3'->5')-2'-deoxy-P-thio-thymidylyl-(3'->5')-2'-deoxy-P-thio-cytidylyl-(3'->5')-2'-deoxy-P-thio-thymidylyl-(3'->5')-2'-O, 4'-C-methylene-5-methyl-P-thio-cytidylyl-(3'->5')-2'-O, 4'-C-methylene-5-methyl-P-thio-uridylyl-(3'->5')-2'-O, 4'-C-methylene-5-methyl-P-thio-uridylyl-(3'->5')-2'-O, 4'-C-methyleneguanosine | 2.16.840.1.113883.3.6905.2
0‑L | 300000057685 | RNA, (Am-sp-(2′-deoxy-2′-fluoro)C-sp-Am-Um-Am-(2′-deoxy-2′-fluoro)A-Gm-(2′-deoxy-2′-fluoro)A-(2′-deoxy-2′-fluoro)C-Am-Um-Um-Am-(2′-deoxy-2′-fluoro)U-Cm-(2′-deoxy-2′-fluoro)C-Um-Am-Am-Um-Gm-sp-Gm-sp-Gm), complex with RNA (Cm-sp-Am-sp-Um-Um-Am-Gm-(2′-deoxy-2′-fluoro)G-Am-(2′-deoxy-2′-fluoro)U-(2′-deoxy-2′-fluoro)A-(2′-deoxy-2′-fluoro)A-Um-Gm-Um-Cm-Um-Um-Am-Um-Gm-Um) 3′-[[(2S,4R)-1-[29-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-14,14-bis[[3-[[3-[[5-[[2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]-1-oxopentyl]amino]propyl]amino]-3-oxopropoxy]methyl]-1,12,19,25-tetraoxo-16-oxa-13,20,24-triazanonacos-1-yl]-4-hydroxy-2-pyrrolidinyl]methyl hydrogen phosphate] (1:1) | 2.16.840.1.113883.3.6905.2
0‑L | 300000013627 | (2S,3S,4S,5R,6R)-3-[(2R,3R,4S,5R,6R)-5-[2-[2-[2-[2-[[(2S)-6-[5-[(3As,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-2-[4-[[(3S)-4-[[(2R)-3-(4-carbamimidoylphenyl)-1-oxo-1-piperidin-1-ylpropan-2-yl]amino]-3-[(4-methoxy-2,3,6-trimethylphenyl)sulfonylamino]-4-oxobutanoyl]amino]butanoylamino]hexanoyl]amino]ethoxy]ethoxy]ethoxy]ethoxy]-3,4-dimethoxy-6-(sulfooxymethyl)oxan-2-yl]oxy-6-[(2R,3R,4S,5R,6R)-6-[(2R,3S,4S,5R,6R)-2-carboxy-6-[(2R,3R,4S,5R,6S)-4,6-dimethoxy-5-sulfooxy-2-(sulfooxymethyl)oxan-3-yl]oxy-4,5-dimethoxyoxan-3-yl]oxy-4,5-disulfooxy-2-(sulfooxymethyl)oxan-3-yl]oxy-4,5-dimethoxyoxane-2-carboxylic acid, octasodium salt | 2.16.840.1.113883.3.6905.2
0‑L | 300000039066 | All-P-ambo-2'-O,4'-C-[(1S)-ethane-1,1-diyl]-P-thioadenylyl-(3'->5')-2'-O,4'-C-[(1S)-ethane-1,1-diyl]-P-thioguanylyl-(3'->5')-P-thiothymidylyl-(3'->5')-P-thiothymidylyl-(3'->5')-2'-deoxy-Pthioguanylyl-(3'->5')-P-thiothymidylyl-(3'->5')-2'-deoxy-Pthioadenylyl-(3'->5')-2'-deoxy-P-thioadenylyl-(3'->5')-2'-deoxy-P-thioadenylyl-(3'->5')-P-thiothymidylyl-(3'->5')-2'-deoxy-Pthioguanylyl-(3'->5')-2'-O-(2-methoxyethyl)-P-thioadenylyl-(3'->5')-2'-O-(2-methoxyethyl)-P-thioguanylyl-(3'->5')-2'-O-(2-methoxyethyl)-5-methyl-P-thiouridylyl-(3'->5')-2'-O,4'-C-[(1S)-ethane-1,1-diyl]-5-methyl-P-thiocytidylyl-(3'->5')-2'-O,4'-C-[(1S)-ethane-1,1-diyl]guanosine sodium (1:15) | 2.16.840.1.113883.3.6905.2
0‑L | 300000042350 | (4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-carboxypropanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-6-aminohexanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-carboxypropanoyl]amino]-6-aminohexanoyl]amino]-3-methylbutanoyl]amino]propanoyl]amino]-5-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-oxopentanoic acid | 2.16.840.1.113883.3.6905.2
0‑L | 100000175540 | (2S,3S,4S,5R,6R)-3-[(2R,3R,4S,5R,6R)-5-[2-[2-[2-[2-[[(2S)-6-[5-[(3As,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-2-[4-[[(3S)-4-[[(2R)-3-(4-carbamimidoylphenyl)-1-oxo-1-piperidin-1-ylpropan-2-yl]amino]-3-[(4-methoxy-2,3,6-trimethylphenyl)sulfonylamino]-4-oxobutanoyl]amino]butanoylamino]hexanoyl]amino]ethoxy]ethoxy]ethoxy]ethoxy]-3,4-dimethoxy-6-(sulfooxymethyl)oxan-2-yl]oxy-6-[(2R,3R,4S,5R,6R)-6-[(2R,3S,4S,5R,6R)-2-carboxy-6-[(2R,3R,4S,5R,6S)-4,6-dimethoxy-5-sulfooxy-2-(sulfooxymethyl)oxan-3-yl]oxy-4,5-dimethoxyoxan-3-yl]oxy-4,5-disulfooxy-2-(sulfooxymethyl)oxan-3-yl]oxy-4,5-dimethoxyoxane-2-carboxylic acid | 2.16.840.1.113883.3.6905.2
0‑L | 300000043979 | (2S,3S,4S,5R,6R)-3-((2R,3R,4S,5R,6R)-5-(2-(2-(2-(2-(4-(((3s)-4-(((1R)-1-((4-carbamimidoylphenyl)methyl)-2-oxo-2-(1-piperidyl)ethyl)amino)-3-((4-methoxy-2,3,6-trimethyl-phenyl)sulfonylamino)-4-oxo-butanoyl)amino)butanoylamino)ethoxy)ethoxy)ethoxy)ethoxy)-3,4-dimethoxy-6-(sulfooxymethyl)tetrahydropyran-2-yl)oxy-6-((2r,3r,4s,5r,6r)-6-((2r,3s,4s,5r,6r)-2-carboxy-6-((2r,3r,4s,5r,6s)-4,6-dimethoxy-5-sulfooxy-2-(sulfooxymethyl)tetrahydropyran-3-yl)oxy-4,5-dimethoxy-tetrahydropyran-3-yl)oxy-4,5-disulfooxy-2-(sulfooxymethyl)tetrahydropyran-3-yl)oxy-4,5-dimethoxy-tetrahydropyran-2-carboxylic acid sodium hydride | 2.16.840.1.113883.3.6905.2
0‑L | 300000051686 | RNA, (Gm-sp-Um-sp-Gm-Cm-(2"-deoxy-2"-fluoro)A-(2"-deoxy-2"-fluoro)C-(2"-deoxy-2"-fluoro)U-Um-Cm-Gm-Cm-Um-Um-Cm-Am-Cm-Am), 3"-[[[rel-(3S,4R)]-1-(9-carboxy-1-oxononyl)-4-(hydroxymethyl)-3,4-dimethyl-3-pyrrolidinyl]methyl hydrogen phosphate], carboxamide with L-glutamoylbis[N-[3,5-bis[[[2-[2-[2-[[2-(acetylamino)-2-deoxy-β-Dgalactopyranosyl]oxy]ethoxy]ethoxy]ethyl]amino]carbonyl]phenyl]glycinamide], sodium salt, complex with RNA (Um-sp-(2"-deoxy-2"-fluoro)G-sp-Um-Gm-Am-Am-GmCm-Gm-Am-Am-Gm-Um-(2"-deoxy-2"-fluoro)G-Cm-(2"-deoxy-2"-fluoro)A-Cm-Am-Cmsp-Gm-sp-Gm-U) sodium salt (1:17:1:21) | 2.16.840.1.113883.3.6905.2
0‑L | 300000042351 | 2-[4-[2-[[1-[2-[[(2R)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(3S,4S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-6-methyl-1-oxoheptan-4-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]piperidin-4-yl]amino]-2-oxoethyl]-7,10-bis(carboxylatomethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate gallium-68(3+) | 2.16.840.1.113883.3.6905.2
0‑L | 100000175547 | ESSENTIAL OIL FROM MELISSA OFFICINALIS LEAF (UP TO 536 MG), INULA HELENIUM ROOT (UP TO 714 MG), ANGELICA ARCHANGELICA ROOT (UP TO 714 MG), ZINGIBER OFFICINALE ROOT (UP TO 714 MG), SYZYGIUM AROMATICUM FLOWER (UP TO 285 MG), ALPINIA OFFICINARUM ROOT (UP TO 285 MG), PIPER NIGRUM FRUIT (UP TO 71 MG), GENTIANA LUTEA ROOT (UP TO 714 MG), MYRISTICA FRAGRANS SEED (UP TO 71 MG), CITRUS AURANTIUM PEEL (UP TO 714 MG), CINNAMOMUM VERUM BARK (UP TO 321 MG), CINNAMOMUM CASSIA FLOWER (UP TO 36 MG) AND ELETTARIA CARDAMOMUM SEED (UP TO 10 MG) | 2.16.840.1.113883.3.6905.2
0‑L | 100000175548 | DISTILLATE FROM A MIXTURE (UP TO): MELISSA OFFICINALIS LEAF (536 MG), INULA HELENIUM ROOT (714 MG), ANGELICA ARCHANGELICA ROOT (714 MG), ZINGIBER OFFICINALE ROOT (714 MG), SYZYGIUM AROMATICUM FLOWER (285 MG), ALPINIA OFFICINARUM ROOT (285 MG), PIPER NIGRUM FRUIT (71 MG), GENTIANA LUTEA ROOT (714 MG), MYRISTICA FRAGRANS SEED (71 MG), CITRUS AURANTIUM PEEL (714 MG), CINNAMOMUM CASSIA BARK (321 MG), CINNAMOMUM VERUM FLOWER (36 MG) AND ELETTARIA CARDAMOMUM SEED (10 MG). EXTRACTION SOLVENTS: ETHANOL 96% (V/V) AND WATER, PURIFIED | 2.16.840.1.113883.3.6905.2
0‑L | 300000026351 | 3,5,8-Trioxa-4-phosphaundec-10-en-1-aminium,4-hydroxy-N,N,N,10-tetramethyl-9-oxo-, inner salt, 4-oxide, homopolymer,9-arm star compd. with 1,1'-[2-[11,11-bis[15-bromo-11,11-bis[(2-bromo-2-methyl-1-oxopropoxy)methyl]-15-methyl-3,7,14-trioxo-9,13-dioxa-2,6-diazahexadec-1-yl]-44-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-4,8,26,42-tetraoxo-2,13,16,19,22,29,32,35,38-nonaoxa-5,9,25,41-tetraazatetratetracont-1-yl]-2-[(2-bromo-2-methyl-1-oxopropoxy)methyl]-1,3-propanediyl] bis(2-bromo-2-methylpropanoate) | 2.16.840.1.113883.3.6905.2
0‑L | 300000042370 | (2R)-3-[[(2R)-1-[[5-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(3S,4S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-6-methyl-1-oxoheptan-4-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]-methylamino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-5-oxopentyl]amino]-1-oxo-3-sulfopropan-2-yl]amino]-2-[(3-cyano-4-(18F)fluoranylbenzoyl)amino]-3-oxopropane-1-sulfonic acid | 2.16.840.1.113883.3.6905.2
0‑L | 100000183786 | 100 ML CONSISTS OF: DISTILLATE FROM A MACERATE OF MELISSA OFFICINALIS LEAF 429-536 MG,HELENII RHIZOMA 226-714 MG, ANGELICA ROOT 209-714 MG, ZINGIBER OFFICINALE RHIZOME 235-714 MG, SYZYGIUM AROMATICUM FLOS 190-285 MG, GALANGAL RHIZOME 70-285 MG, PIPER NIGRUM FRUIT 16-71 MG, GENTIANA ROOT 571-714 MG, NUTMEG SEEDS 36-71 MG, BITTER-ORANGE EPICARP AND MESOCARP 99-714 MG, CINNAMOMI CORTEX 223-321 MG, CINNAMON BLOSSOM 15-36 MG, CARDAMOMI FRUCTUS 6-10 MG: EXTRACTION SOLVENT: ETHANOL 79% (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000052116 | (4S)-4-[(2-Aminoacetyl)amino]-5-[(2S)-2-[(2S)-2-[(2S)-2-[[2-[[(2S)-6-amino-1-[(2S)-2-[[(2S)-1-[[(2S)-3-carboxy-1-[[(2S)-3-carboxy-1-[[(2S)-1-[[2-[[(2S)-1-[[(1S)-1-carboxy-2-methylpropyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxohexan-2-yl]amino]-2-oxoethyl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-5-oxopentanoic acid | 2.16.840.1.113883.3.6905.2
0‑L | 100000174602 | TINCTURE FROM BLACK POPLAR BUD, CAPSICUM, CLOVE, OAK BARK, CALENDULA, FLOWER, BAY LAUREL LEAF, PEPPERMINT LEAF, DILL FRUIT, HAWTHORN BERRIES, WORMWOOD, ALLSPICE, LOVAGE ROOT, VALERIAN ROOT, HOP STROBILE, BITTER-ORANGE EPICARP AND MESOCARP, FRANGULA BARK, WILLOW BARK, CARAWAY FRUIT, BIRCH LEAF, MEADOWSWEET, ST. JOHN'S WORT, HYSSOP, YARROW, THYME, TORMENTIL, ROWAN FRUIT, DOG ROSE (10,5/0,3/5/2/2/5/2/2/2/2/2/2/2/2/3/6/6/6/6/6/6/6/6/6/6/12/12), EXTRACTION SOLVENT: ETHANOL 40% V/V | 2.16.840.1.113883.3.6905.2
0‑L | 300000013162 | Poly[2-[(4-{[1-carboxy-2-(hexadecylcarbamoyl)ethyl]sulfanyl}-2,3-bis({2-[((2S)-2-(2-{[(2R)-2-carbamoyl-(2-{[(2S)-1-ethoxy-3-(3-hydroxy-4oxo-1,4-dihydropyridin-1-yl)-1-oxopropan-2-yl]carbamoyl}ethyl]sulfanyl}-3-{[(2S)-1-ethoxy-3-(3-hydroxy-4-oxo-1,4-dihydropyridin-1-yl)-1-oxopropan-2-yl]carbamoyl}propanamido)-3-(3-hydroxy-4-oxo-1,4-dihydropyridin-1-yl)propanoyl ethyl ester))-methoxy]acetyl}oxy)butyl)sulfanyl]-3-(hexadecylcarbamoyl)propanoic acid]-poly(ethylene glycol)-ester] | 2.16.840.1.113883.3.6905.2
0‑L | 300000039033 | (3RS)-1-[(6S,9S)-1-amino-6-[(4-{[({(2S)-2-hydroxy-3-[(12S,13S,14R,15R,32R,34R,36S,62S,65S,92S,93aR,94aR,95S,95aS,97R,99aS,910aR,910bS)-14-methoxy-34-methyl-33,63-bis(methylidene)-11-oxo-9-decahydro-93H-9(2,7)-(2,5-epoxyfuro[2',3':4,5]furo[3,2-b]pyrano[2,3-e]pyrana)-3(2,6)-oxana- 1(2,3),6(2,5)-bis(oxolana)cyclododecaphan-15yl]propyl}carbamoyl)oxy]methyl}phenyl)carbamoyl]-1,8,11-trioxo-9-(propan-2-yl)-14,17-dioxa-2,7,10-triazanonadecan-19-yl]-2,5-dioxopyrrolidin-3-yl | 2.16.840.1.113883.3.6905.2
0‑L | 300000044789 | L-methionylglycyl-L-seryl-L-serylhexa-L-histidyl-L-seryl-L-serylglycyl-L-leucyl-L-valyl-L-prolyl-larginylglycyl-L-seryl-L-histidyl-L-methionyl-L-alanyl-L-seryl-L-methionyl-L-threonylglycylglycyll-glutaminyl-L-glutaminyl-L-methionylglycyl-L-arginyl-L-aspartyl-L-prolyl-des-(1-25)-cysteineproteinase EP-B 2 precursor (Hordeum vulgare) fusion protein with l-asparaginyl-tri-lseryl-L-valyl-L-aspartyl-L-lysyl-L-leucyl-tri-L-alanyl-L-leucyl-L-glutamylhexa-L-histidine | 2.16.840.1.113883.3.6905.2
0‑L | 300000015302 | RNA, [P-deoxy-P-(dimethylamino)] (2',3'-dideoxy-2',3'-imino-2',3'-seco) (2'a->5') (C-m5U-m5U-A-C-A-G-G-C-m5U-C-C-A-A-m5U-A-G-m5U-G-G-m5U-C-A-G-m5U), 5' [P-[4-[[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]carbonyl]-1-piperazinyl]-N,N-dimethylaminophosphonamidate], 3' [2'a-[N2-acetyl-L-arginyl-6-aminohexanoyl-L-arginyl-L-arginyl-beta-alanyl-L-arginyl-L-arginyl-6-aminohexanoyl-L-arginyl-L-arginyl-beta-alanyl-L-arginyl-6-aminohexanoyl-beta-alanyl], octahydrochloride | 2.16.840.1.113883.3.6905.2
0‑L | 300000028882 | N-[6-(1-{2-[3,6-bis(2,3-dihydro-1H-indol-1-yl)xanthylium-9-yl]benzene-1-sulfonyl}piperidine-4-carboxamido)hexanoyl]glycylglycyl-L-arginyl-N6-(6-{2-[(1E,3E,5Z)-5-(1-ethyl-3,3-dimethyl-5-sulfonato-1,3-dihydro-2H-indol-2-ylidene)penta-1,3-dien-1-yl]-3,3-dimethyl-5-sulfonato-3H-indol-1-ium-1-yl}hexanoyl)-Llysyl-[2-(2-aminoethoxy)ethoxy]acetyl-S-[(3RS)-1-{6-[α-methylpoly(oxyethylene)-ω-amino]-6-oxohexyl}-2,5-dioxopyrrolidin-3-yl]-L-cysteinamide acetate | 2.16.840.1.113883.3.6905.2
0‑L | 100000137876 | DISTILLATE OF MELISSA LEAF (536 MG/100 ML), HELENII RHIZOMA (714 MG/100 ML), ANGELICA ROOT (714 MG/100 ML), ZINGIBER OFFICINALE (GINGER) ROOT (714 MG/100 ML), CLOVES (285 MG/100 ML), GALANGAL RHIZOME (285 MG/100 ML), BLACK PEPPER FRUITS (71 MG/100 ML), GENTIAN ROOT (714 MG/100 ML), NUTMEG SEEDS (71 MG/100 ML), BITTER ORANGE PEEL (714 MG/100 ML), CINNAMOMI CORTEX (321 MG/100 ML), CINNAMON BLOSSOM (36 MG/100 ML), CARDAMOM SEEDS (10 MG/100 ML) | 2.16.840.1.113883.3.6905.2
0‑L | 300000051639 | L-threonyl-L-lysyl-L-phenylalanyl-Lthreonyl-L-leucyl-L-seryl-L-leucyl-L-aspartyl-L-valyl-L-prolyl-l-threonyl-L-asparaginylL-isoleucyl-L-methionyl-L-asparaginyl-L-leucyl-L-leucyl-L-phenylalanyl-L-asparaginylL-isoleucyl-L-alanyl-L-lysyl-L-alanyl-L-lysyl-L-asparaginyl-L-leucyl-L-arginyl-Lalanyl-L-glutaminyl-L-alanyl-L-alanyl-L-alanyl-L-asparaginyl-L-alanyl-L-histidyl-Lleucyl-L-methionyl-L-alanyl-L-glutaminyl-L-isoleucine amide acetate | 2.16.840.1.113883.3.6905.2
0‑L | 300000044774 | (3RS)-1-(6-{[(2S)-1-({(2S)-5-(carbamoylamino)-1-[4-({[(1-{[(2S)-1-{[(3R,4S,5S)-3-methoxy-1-{(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-{[(1S)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino}propyl]pyrrolidin-1-yl}-5-methyl-1-oxoheptan-4-yl](methyl)amino}-3-methyl-1-oxobutan-2-yl]amino}-2-methyl-1-oxopropan-2-yl)carbamoyl]oxy}methyl)anilino]-1-oxopentan-2-yl}amino)-3-methyl-1-oxobutan-2-yl]amino}-6-oxohexyl)-2,5-dioxopyrrolidin-3-yl | 2.16.840.1.113883.3.6905.2
0‑L | 300000041538 | 4-[4-carboxybutyl-[2-[(18S,25S,35S)-35-[(S)-hydroxy(phenyl)methyl]-28-(methoxymethyl)-21-methyl-18-[2-(methylamino)-2-oxoethyl]-16,23,30,33-tetraoxo-25-propan-2-yl-3,13,20,27,37-pentathia-7,17,24,31,34,39,40,41,42,43-decazaheptacyclo[34.2.1.12,5.112,15.119,22.126,29.06,11]tritetraconta-1(38),2(43),4,6(11),7,9,12(42),14,19(41),21,26(40),28,36(39)-tridecaen-8-yl]-1,3-thiazol-4-yl]carbamoyl]oxycyclohexane-1-carboxylic acid | 2.16.840.1.113883.3.6905.2
0‑L | 300000044630 | (3RS)-1-(6-{[(1S)-1-{[(1S)-4-(carbamoylamino)-1-({4-[({[(1S)-1-{[(1S)-1-({(1S,2R)-4-{(2S)-2-[(1R,2R)-3-{[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]amino}-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl}-2-methoxy-1-[(1S)-1-methylpropyl]-4-oxobutyl}methylcarbamoyl)-2-methylpropyl]carbamoyl}-2-methylpropyl]methylcarbamoyl}oxy)methyl]phenyl}carbamoyl)butyl]carbamoyl}-2-methylpropyl]amino}-6-oxohexyl)-2,5-dioxopyrrolidin-3-yl | 2.16.840.1.113883.3.6905.2
0‑L | 100000175549 | ESSENTIAL OIL DISTILLED IN A 4.04 G ALCOHOL MIXTURE: MELISSA OFFICINALIS LEAF 10.48%, INULA HELENIUM ROOT 13.96%, ANGELICA ARCHANGELICA ROOT 13.96%, ZINGIBER OFFICINALE ROOT 13.96%, SYZYGIUM AROMATICUM FLOWER 5.57%, ALPINIA OFFICINARUM ROOT 5.57%, PIPER NIGRUM FRUIT 1.39%, GENTIANA LUTEA ROOT 13.96%, CITRUS AURANTIUM PEEL 13.96%, CINNAMOMUM CASSIA 6.28%,CINNAMOMUM VERUM FLOWER 0.7% AND ELETTARIA CARDAMOMUM SEEDS 0.2% | 2.16.840.1.113883.3.6905.2
0‑L | 100000138035 | DISTILLATE OF MELISSA LEAF (536 MG/100 ML), HELENII RHIZOMA (714 MG/100 ML), ANGELICA ROOT (714 MG/100 ML), ZINGIBER OFFICINALE (GINGER) ROOT (714 MG/100 ML), CLOVES (285 MG/100 ML), GALANGAL RHIZOME (285 MG/100 ML), BLACK PEPPER FRUITS (71 MG/100 ML), GENTIAN ROOT (714 MG/100 ML), BITTER ORANGE PEEL (714 MG/100 ML), CINNAMOMI CORTEX (321 MG/100 ML), CINNAMON BLOSSOM (36 MG/100 ML), CARDAMOM SEEDS (10 MG/100 ML) | 2.16.840.1.113883.3.6905.2
0‑L | 300000056945 | N-Acetyl-L-alanyl-L-seryl-L-histidyl-L-leucyl-L-seryl-L-threonyl-L-alanyl-L-valyl-L-leucylglycyl-N6-[(22S)-22,42-dicarboxy-10,19,24-trioxo-3,6,12,15-tetraoxa-9,18,23-triazadotetracontan-1-oyl]-L-lysyl-L-leucyl-L-seryl-2-methylalanyl-L-glutamyl-L-leucyl-L-histidyl-L-lysyl-L-leucyl-L-glutamyl-L-aspartyl-L-tyrosinyl-L-prolyl-L-arginyl-L-threonyl-L-aspartyl-L-valylglycyl-L-alanyl-L-glutamyl-L-seryl-L-prolinamide | 2.16.840.1.113883.3.6905.2
0‑L | 100000183261 | (E)-2-((2s,4s)-4-(((2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl)-10-(carboxymethyl)-1-hydroxy-13-(2-(2-(2-((e)-3-(3-((3-hydroxy-3,3 diphosphonopropyl)(methyl)amino)propoxy)benzylidene)hydrazine-1-carbonothioyl)hydrazineyl)-2-oxoethyl)-8-oxo-5-thioxo-3,4,6,7,10,13-hexaazapentadec-2-en-15-oic acid | 2.16.840.1.113883.3.6905.2
0‑L | 300000044783 | N-[10,10-dioxido-1,12-dioxo-14-[(1α,8α,9β)-bicyclo[6.1.0]non4-yn-9-yl]-3,6,13-trioxa-10-thia-9,11-diazatetradec-1-yl]-L-valyl-N-[4-[[[[(11S,11aS)-8-[[5-[[(11aS)-5,11a-dihydro-7-methoxy-2-methyl-5-oxo-1Hpyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]pentyl]oxy]- 11,11a-dihydro-11-hydroxy-7-methoxy-2-methyl-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepin10(5H)-yl]carbonyl]oxy]methyl]phenyl]-L-alaninamide | 2.16.840.1.113883.3.6905.2
0‑L | 300000044100 | [Oxybis(1,1,1,5,5,5-hexamethyltrisiloxane-3,3-diyl)]bis(propane-3,1-diyl) bis(2-methylacrylate), polymer with N,N-dimethylacrylamide, 1-vinylpyrrolidin-2-one, hexane1,6-diyl diacrylate, 2-hydroxyethyl methacrylate, methyl methacrylate, 1,1,1,3,3,3- hexafluoropropan-2-yl methacrylate, 3-(1,1,1,5,5,5-hexamethyl-3-((trimethylsilyl)oxy)trisiloxan-3-yl)propyl methacrylate and allyl methacrylate | 2.16.840.1.113883.3.6905.2
0‑L | 300000052292 | 2-[4-[2-[[(2R)-1-[[(4R,7S,10S,13R,16S,19R)-10-(4-Aminobutyl)-4-[[(2R,3R)-1,3-dihydroxybutan-2-yl]carbamoyl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-16-(naphthalen-1-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]-7,10-bis(carboxylatomethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate gallium-68(3+) | 2.16.840.1.113883.3.6905.2
0‑L | 300000042310 | Cyclohexanecarboxylic acid, 4-[(2,5-dihydro-2,5-dioxo-1H-pyrrol-1- yl)methyl]-, 2-[2-[[O-6-deoxy-alfa-L-galactopyranosyl-(1->2)-O- beta-D-galactopyranosyl-(1->3)-O-2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl-(1->3)-O-alfa-D-galactopyranosyl-(1->4)-O- beta-D-galactopyranosyl-(1->4)-beta-D- glucopyranosyl]oxy]ethyl]hydrazide, reaction products with hemocyanin keyhole limpet | 2.16.840.1.113883.3.6905.2
0‑L | 300000051875 | 5-{[(2S)-1-{[(2S)-1-{4-[(5S,8S,11S,12R)-11-[(2S)-Butan-2-yl]-12-(2-{(2S)-2-[(1R,2R)-3-{[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino}-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl}-2-oxoethyl)-4,10-dimethyl-3,6,9-trioxo-5,8-di(propan-2-yl)-2,13-dioxa-4,7,10-triazatetradecan-1-yl]anilino}-5-(carbamoylamino)-1-oxopentan-2-yl]amino}-3-methyl-1-oxobutan-2-yl]amino}-5-oxopentanoyl | 2.16.840.1.113883.3.6905.2
0‑L | 300000008875 | L-cysteinyl-L-tryptophyl-L-leucyl-L-cysteinyl-L-arginyl-L-alanyl- L-leucyl-L-isoleucyl-L-lysyl-L-arginyl-L-isoleucyl-L-glutaminyl-L-alanyl-L- leucyl-L-isoleucyl-L-prolyl-L-lysylglycylglycyl-L-arginyl-L-leucyl-L- leucyl-L-prolyl-L-glutaminyl-L-leucyl-L-valyl-L-cysteinyl-L-arginyl-L- leucyl-L-valyl-L-leucyl-L-arginyl-L-cysteinyl-L-serine, cyclic (1->33),(4->27)-bis(disulfide) | 2.16.840.1.113883.3.6905.2
0‑L | 300000033220 | (2R)-3-(((2-(6-((3-(((2R,3R,4R,5S,6R)-3-acetamido-5-(((2S,3R,4S,5S,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-(((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2Hpyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-4-hydroxy-6-(hydroxymethyl)tetrahydro -2Hpyran-2-yl)oxy)propyl)amino)-6-oxohexanamido)ethoxy)(hydroxy)phosphoryl)oxy) propane-1,2-diyl dioleate, sodium salt | 2.16.840.1.113883.3.6905.2
0‑L | 300000041342 | 2-[4-[2-[[(2R)-1-[[(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-4-[[(2R,3R)-1,3-dihydroxybutan-2-yl]carbamoyl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-16-(naphthalen-1-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]-7,10-bis(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetic acid | 2.16.840.1.113883.3.6905.2
0‑L | 300000051873 | 5-(6-{[(1-{(34S)-38-Amino-34-[(4-{[({[(4S)-4-ethyl-11-{2-[N-(propan-2-yl)methanesulfonamido]ethyl}-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl]oxy}carbonyl)oxy]methyl}phenyl)carbamoyl]-28,32-dioxo-3,6,9,12,15,18,21,24,30-nonaoxa-27,33-diazaoctatriacontan-1-yl}-1H-1,2,3-triazol-4-yl)methyl]amino}-6-oxohex-1-yn-1-yl)pyrimidin-2-yl | 2.16.840.1.113883.3.6905.2
0‑L | 300000056685 | 2'-O-4'-C-(S)-Ethyl-P-thioadenylyl-(3'-O->5'-O)-2'-O-4'-C-(S)-ethyl-P-thioguanylyl-(3'-O->5'-O)-2'-O-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-fluoro-P-thioadenylyl-(3'-O->5'-O)-2'-fluoro-P-thiocytidylyl-(3'-O->5'-O)-2'-fluoro-P-thiouridylyl-(3'-O->5'-O)-2'-O-methyl-P-thiouridylyl-(3'-O->5'-O)-2'-O-4'-C-(S)-ethyl-P-thiouridylyl-(3'-O->5'-O)-2'-O-4'-C-(S)-ethyl-adenosine | 2.16.840.1.113883.3.6905.2
0‑L | 300000057543 | (2S)-2-Cyclopentyl-2-[(5S)-2-[(2R,3R)-3-cyclopropyl-1-methylaziridine-2-carbonyl]-2,7-diazaspiro[4.4]nonan-7-yl]-N-[(6S,8S,14S)-21-[5-(4-cyclopropylpiperazin-1-yl)-2-[(1S)-1-methoxyethyl]pyridin-3-yl]-18,18-dimethyl-9,15-dioxo-22-(2,2,2-trifluoroethyl)-5,16-dioxa-2,10,22,28-tetrazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),20,23(27),24-tetraen-8-yl]acetamide | 2.16.840.1.113883.3.6905.2
0‑L | 300000050554 | 2R,4R,5S,6S)-5-Acetamido-2-[[(2R,3S,4S,5R,6S)-5-[(2R,3S,4S,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(E,2R,3S)-3-hydroxy-2-(octadecanoylamino)octadec-4-enoxy]oxan-3-yl]oxy-3-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxymethyl]-4-hydroxy-6-[(1S,2S)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid | 2.16.840.1.113883.3.6905.2
0‑L | 300000033238 | (2R)-3-(((2-(6-((3-(((2R,3R,4R,5S,6R)-3-acetamido-5-(((2S,3R,4S,5S,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-(((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2Hpyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-4-hydroxy-6-(hydroxymethyl)tetrahydro -2Hpyran-2-yl)oxy)propyl)amino)-6-oxohexanamido)ethoxy)(hydroxy)phosphoryl)oxy) propane-1,2-diyl dioleate | 2.16.840.1.113883.3.6905.2
0‑L | 300000045067 | (2S)-5-(carbamoylamino)-N-[4-[[(2R,3R)-3-[(2S)-1-[(3R,4S,5S)-4-[[(2S)-2-[[(2S)-2-(dimethylamino)-3-methylbutanoyl]amino]-3-methylbutanoyl]-methylamino]-3-methoxy-5-methylheptanoyl]pyrrolidin-2-yl]-3-methoxy-2-methylpropanoyl]sulfamoyl]phenyl]-2-[[(2S)-2-[3-[2-[2-[2-(2,5-dioxopyrrol-1-yl)ethoxy]ethoxy]ethoxy]propanoylamino]-3-methylbutanoyl]amino]pentanamide | 2.16.840.1.113883.3.6905.2
0‑L | 100000166260 | LIQUID EXTRACT (1 : 10.6-13.0) OF ARTICHOKE LEAF, GENTIAN ROOT, TURMERIC ROOT, DANDELION HERB WITH ROOT, GINGER, YARROW HERB, BITTER FENNEL, MATRICARIA FLOWER, BITTER-ORANGE EPICARP AND MESOCARP, BLESSED THISTLE, BOGBEAN LEAF, CARDAMOM, WORMWOOD (41.5 : 11.8 : 8.5 : 7.2 : 5.9 : 5.8 : 5.8 : 4.3 : 4.3 : 2.1 : 1.0 : 1.0 : 0.57), EXTRACTION AGENT: WATER | 2.16.840.1.113883.3.6905.2
0‑L | 300000046505 | (S)-1-(acetyl-L-prolyl-L-prolyl)-N-((S)-1-((S)-2-(((S)-1-(((S)-1-(((S)-1-(((2S,3S)-1-(((S)-1,6-diamino-1-oxohexan-2-yl)amino)-3-methyl-1-oxopentan-2-yl)amino)-5-guanidino-1-oxopentan-2-yl)amino)-1-oxopropan-2-yl)amino)-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl)carbamoyl)pyrrolidin-1-yl)-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl)pyrrolidine-2-carboxamide | 2.16.840.1.113883.3.6905.2
0‑L | 300000057717 | N-[N6-[N-(17-Carboxy-1-oxoheptadecyl)-L-gamma-glutamyl-2-[2-(2-aminoethoxy)ethoxy]acetyl-2-[2-(2-aminoethoxy)ethoxy]acetyl-L-gamma-glutamyl]-D-lysyl-N-methylglycyl]-32a-[N6-[N-(17-carboxy-1-oxoheptadecyl)-L-γ-glutamyl-2-[2-(2-aminoethoxy)ethoxy]acetyl-2-[2-(2-aminoethoxy)ethoxy]acetyl-L-γ-glutamyl]-L-lysine]-1-32-human parathyroid hormone | 2.16.840.1.113883.3.6905.2
0‑L | 300000001485 | N1-(2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl)-N6-((S)-1-(((S)-1-((3-((((S)-8-methoxy-6-oxo-11,12,12a,13-tetrahydro-6H-benzo[5,6][1,4]diazepino[1,2-a]indol-9-yl)oxy)methyl)-5-((((S)-8-methoxy-6-oxo-12a,13-dihydro-6H-benzo[5,6][1,4]diazepino[1,2-a]indol-9-yl)oxy)methyl)phenyl)amino)-1-oxopropan-2-yl)amino)-1-oxopropan-2-yl)adipamide | 2.16.840.1.113883.3.6905.2
0‑L | 300000051687 | 4-{2-[(E)-(2-{4-[(2S,5S,20S,24S)-5-Benzyl-2,20,24,26-tetracarboxy-4,7,17,22-tetraoxo-10,13-dioxa-3,6,16,21,23-pentaazahexacosyl]phenoxy}-3-{(E)-2-[(2E)-3,3- dimethyl-5-sulfo-1-(4-sulfobutyl)-1,3-dihydro-2H-indol-2-ylidene]ethylidene}cyclohex-1-en-1-yl)ethenyl]-3,3-dimethyl-5-sulfo-3H-indol-1-ium-1-yl}butane-1-sulfonate heptasodium | 2.16.840.1.113883.3.6905.2
0‑L | 300000031093 | Sodium 1-(1-carboxy-4,21-dioxo-1-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl)-8,11,14,17-tetraoxa-5,20-diazahexacosan-26-yl)-2-((E)-2-((E)-3-(2-((E)-3,3-dimethyl-5-sulfonato-1-(4-sulfonatobutyl)indolin-2-ylidene)ethylidene)-2-(4-sulfonatophenoxy)cyclohex-1-en-1-yl)vinyl)-3,3-dimethyl-3H-indol-1-ium-5-sulfonate | 2.16.840.1.113883.3.6905.2
0‑L | 300000005660 | S-[5-(omega-methoxypoly(oxyethylene)-2-oxopentyl)]-L-cysteinylglycyl-L-serinylglycylgylcyl-L-isoleucyl-L-lysyl-L-glutamyl-L-phenylalanyl-L-leucyl-L-glutaminyl-L-arginyl-L-phenylalanyl-L-isoleucyl-L-histyl-L-isoleucyl-L-valyl-L-glutaminyl-L-serinyl-L-isoleucyl-L-isoleucyl-L-asparaginyl-L-threonyl-L-serinamide, acetate salt | 2.16.840.1.113883.3.6905.2
0‑L | 300000040910 | (2S,3R)-2-[[(3S)-4-amino-3-(3-chlorophenyl)butanoyl]amino]-N-[(2S)-3-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]propan-2-yl]-3-hydroxybutanamide acetic acid salt | 2.16.840.1.113883.3.6905.2
0‑L | 300000014560 | Adalimumab conjugated with (4S)-4-[2-(2-bromoacetamido)acetamido]-5-{3-[(4-{(4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-4a,6a-dimethyl-2-oxo-6b-[(phosphonooxy)acetyl]-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H,8H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8-yl}phenyl)methyl] anilino}-5-oxopentanoic acid | 2.16.840.1.113883.3.6905.2
0‑L | 100000142686 | QUERCUS ROBUR/PETRAEA E CORTICE CUM CALCIO CARBONICO = D6 SOLUTION (PREPARED FROM QUERCUS ROBUR/PETRAEA E CORTICE, DECOCTUM Ø (HAB VS.23A) BY FOUR-TIME POTENTIATION WITH SATURATED AQUEOUS SOLUTION OF CALCIUM CARBONICA E CINERE QUERCUS AND SUBSEQUENT POTENTIATION WITH SUGAR SYRUP PRODUCED THERE FROM)(HAB, SV5B) | 2.16.840.1.113883.3.6905.2
0‑L | 100000139492 | EXTRACTUM COMPOSITUM (1:1,3-1,6) EX: AGROPYRI RHIZOMATE 12,5 P.,ALLII CEPAE SQUAMA 5,0 P.,BETULAE FOLIO 10,0 P.,FOENUGRAECI SEMINE 15,0 P.,PETROSELINI RADICE 17,5 P.,SOLIDAGINIS HERBA 5,0 P.,EQUISETI HERBA 10,0 P.,LEVISTICI RADICE 10,0 P.,POLYGONI AVICULARIS HERBA 15,0 P. – 67,2 GEKSTRAHENT – ETANOL 45% (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000046886 | Benzoic acid, 2-hydroxy-, monosodium salt, mixture with 2-(diethylamino)ethyl-4-aminobenzoate monohydrochloride, 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione, 5,5-di-2-propenyl-2,4,6(1H,3H,5H)-pyrimidinetrione and sodium ((2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)methylamino)methanesulfonate | 2.16.840.1.113883.3.6905.2
0‑L | 300000050816 | 1-((1R,2S)-1-((((2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1h-cyclodeca(3,4)benz(1,2-b)oxet-9-yl)oxy)carbonyl)-2-(((1,1-dimethylethoxy)carbonyl)amino)-2-phenylethyl) butanedioate | 2.16.840.1.113883.3.6905.2
0‑L | 300000037118 | Grass pollen allergen extract from Agrostis capillaris/tenuis, Bromus spp., Dactylis glomerata, Cynosurus cristatus, Secale cereale, Arrhenatherum elatius, Festuca pratensis, Alopecurus pratensis, Poa pratensis/trivialis, Lolium perenne/multiflorum, Anthoxanthum odoratum, Phleum pratense and Holcus lanatus | 2.16.840.1.113883.3.6905.2
0‑L | 300000008876 | L-isoleucyl-L-prolyl-L-seryl-L-seryl-L-prolyl-L-valyl-L- histidyl-L-leucyl-L-lysyl-L-arginyl-L-leucyl-L-lysyl-L-leucyl-L-leucyl-L- leucyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-isoleucyl-L-leucyl-L- leucyl-L-leucyl-L-isoleucyl-L-leucylglycyl-L-alanyl-L-leucyl-L-leucyl-L- leucylglycyl- L-leucine | 2.16.840.1.113883.3.6905.2
0‑L | 100000169535 | DESTILLATE OF MELISSA LEAF, CLOVE, ANGELICA ROOT, LAVENDER FLOWER, CINNAMON, NUTMEG FLOWER, NUTMEG SEED, CHINESE CINNAMON, SPEARMINT LEAF, PEPPERMINT LEAF, WORMWOOD, GENTIAN ROOT, CORIANDER FRUIT (9,1 : 7,6 : 5 : 2,5 : 2,5 : 2,5 : 2,5 : 2,5 : 1,5 : 1 : 1 : 1 : 1), DISTILLATION AGENT: ETHANOL 70% (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000055873 | S3.1,S3.6-cyclo[N-acetyl-3-sulfanyl-L-valyl-L-asparaginyl-L-threonyl-7- methyl-L-tryptophyl-N6-acetyl-L-lysyl-3-sulfanyl-L-valyl-O-(2- aminoethyl)-L-tyrosyl-3-(naphthalen-2-yl)-L-alanyl-4-aminooxan-4- carbonyl-L-alfa-glutamyl-L-asparaginyl-3-(pyridin-3-yl)-L-alanyl-N2- methylglycinamide] hydrochloride | 2.16.840.1.113883.3.6905.2
0‑L | 300000052140 | Humanised IgG1 monoclonal antibody against HER2 conjugated to (2S)-2-((2-amino-2-methyl-propanoyl)amino)-N-((1S,2R)-2-methoxy-4-((2S)-2-((1R,2R)-1-methoxy-2-methyl-3-oxo-3-(((1S)-2-phenyl-1-thiazol-2-yl-ethyl)amino)propyl)pyrrolidin-1-yl)-1-((1S)-1-methylpropyl)-4-oxo-butyl)-N,3-dimethyl-butanamide | 2.16.840.1.113883.3.6905.2
0‑L | 300000027131 | Mixture of allergen extracts from Alopecurus pratensis, Cynosurus cristatus, Dactylis glomerata, Lolium perenne, Poa pratensis, Anthoxanthum odoratum, Festuca pratensis, Agrostis tenuis, Phleum pratense, Bromus spp., Arrhenatherum elatius, Holcus lanatus and Secale cereale, Glutaraldehyde-modified | 2.16.840.1.113883.3.6905.2
0‑L | 300000052175 | (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S,34R)-30-Ethyl-34-[(E,2R)-hex-4-en-2-yl]-4,7,10,12,15,19,25,28-octamethyl-33-(methylamino)-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1-oxa-4,7,10,13,16,19,22,25,28,31-decazacyclotetratriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone hydrochloride | 2.16.840.1.113883.3.6905.2
0‑L | 300000056618 | (4S)-4,11-Diethyl-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl-N-{1-[4-({[(1R)-2-carboxy-1-(3-{3-[(propylcarbamoyl)amino]benzene-1-sulfonamido}phenyl)ethyl]carbamoyl}amino)anilino]-1-oxo-5,8,11-trioxa-2-azatetradecan-14-oyl}-L-alfa-aspartyl-L-prolyl-L-valinate | 2.16.840.1.113883.3.6905.2
0‑L | 300000044605 | (2RS,12S)-14-[(1S,2R,3S,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110.14.03.5]hexacosa-10,12,14(26),16,18-pentaen-6-yl]-7,7,11,12-tetramethyl-10,13-dioxo-2-sulfonyl-14-oxa-5,6-dithia-11-azatetradecanoic acid | 2.16.840.1.113883.3.6905.2
0‑L | 300000049039 | Preparation of Symphytum x uplandicum herb (DER 0.2-0.9:1), composed of 40 % liquid extract from Symphytum x uplandicum herb, extraction solvent: water, and 60 % liquid extract from the press residue after aqueous extraction of Symphytum x uplandicum herb, extraction solvent: ethanol 30 % (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000050922 | Preparation of Symphytum x uplandicum herb (DER 0.5-0.7:1), composed of 40 % liquid extract from Symphytum x uplandicum herb, extraction solvent: water, and 60 % liquid extract from the press residue after aqueous extraction of Symphytum x uplandicum herb, extraction solvent: ethanol 30 % (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000041430 | (2Z,4S,6S,9R,10R,18S,21S,24R,25Z,27R,28R,30R,32S)-10,27-dihydroxy-21-[(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl]-4,28-dimethoxy-3,9,24,26,30,32-hexamethyl-34-phenyl-20,35,38-trioxa-13,34-diazatetracyclo[31.2.2.16,10.013,18]octatriaconta-2,25-diene-11,12,19,23,29-pentone | 2.16.840.1.113883.3.6905.2
0‑L | 300000042571 | (1S,2R,5R,7R,8R,9R,11R,13R,14R)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-15-[1-[(3-hydroxy-1,5-naphthyridin-4-yl)methyl]azetidin-3-yl]-9-methoxy-1,5,7,9,11,13-hexamethyl-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone (E)-but-2-enedioic acid | 2.16.840.1.113883.3.6905.2
0‑L | 300000001720 | (1R,3R,15E,28R,29R,30R,31R,34R,36R,39S,41R)-29,41-difluoro-34,39-bis(sulfanyl)- 2,33,35,38,40,42-hexaoxa-4,6,9,11,13,18,20,22,25,27-decaaza-34delta5,39delta5-diphosphaoctacyclo[28.6.4.13,36.128,31.04,8.07,12.019,24.023,27]dotetraconta-5,7,9,11,15,19,21,23,25-nonaene-34,39-dione diammonia | 2.16.840.1.113883.3.6905.2
0‑L | 300000033240 | S3,1, S3,6-Cyclo[N-acetyl-3-sulfanyl-L-valyl-L-asparaginyl-L-threonyl-7-methyl-L-tryptophyl-N6-acetyl-L-lysyl-3-sulfanyl-L-valyl-O-(2-aminoethyl)-L-tyrosyl-3-(naphthalen-2-yl)-L-alanyl-4-aminooxan-4-carbonyl-L-alpha-glutamyl-L-asparaginyl-3-(pyridin-3-yl)-L-alanyl-N2-methylglycinamide] | 2.16.840.1.113883.3.6905.2
0‑L | 300000055796 | 3-(1-(2-((S)-2-(3-Cyclopropyl-4-fluorophenyl)-3-(3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-5-carbonyl)-7-((S)-2,2-dimethyltetrahydro-2Hpyran-4-yl)indolizin-3-yl)cyclopropyl)-1,2,4-oxadiazol-5(4H)-one | 2.16.840.1.113883.3.6905.2
0‑L | 300000056939 | (1R,2R,4S)-4-{(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,32S,35R)-1,18-Dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-methyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-12-yl]propyl}-2-methoxycyclohexyl cyclohexanecarboxylate | 2.16.840.1.113883.3.6905.2
0‑L | 300000040432 | [(1R)-1-[(3S,6S,9S,12S,18R,21S,22R)-21-acetamido-18-benzyl-3-[(1R)-1-methoxyethyl]-4,9,10,12,16-pentamethyl-15-methylidene-2,5,8,11,14,17,20-heptaoxo-22-propan-2-yl-1,19-dioxa-4,7,10,13,16-pentazacyclodocos-6-yl]-2-methylpropyl] (2S,3R)-3-hydroxy-4-methyl-2-(propanoylamino)pentanoate | 2.16.840.1.113883.3.6905.2
0‑L | 300000052174 | (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S,34R)-30-Ethyl-34-[(E,2R)-hex-4-en-2-yl]-4,7,10,12,15,19,25,28-octamethyl-33-(methylamino)-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1-oxa-4,7,10,13,16,19,22,25,28,31-decazacyclotetratriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone | 2.16.840.1.113883.3.6905.2
0‑L | 300000041793 | N-epsilon-palmitoyl-L-lysyl-N-epsilon-palmitoyl-L-lysyl-L-aspartyl-L-alanyl-L-glutamyl-L-phenylalanyl-L-arginyl-L-histidyl-L-aspartyl-L-seryl-glycyl-L-tyrosyl-L-glutamyl-L-valyl-L-histidyl-L-histidyl-L-glutaminyl-N-epsilon-palmitoyl-L-lysyl-N-epsilon-palmitoyl-L-lysine, acetate salt | 2.16.840.1.113883.3.6905.2
0‑L | 300000027132 | Mixture of allergen extracts from Alopecurus pratensis, Cynosurus cristatus, Dactylis glomerata, Lolium perenne, Poa pratensis, Anthoxanthum odoratum, Festuca pratensis, Agrostis tenuis, Phleum pratense, Bromus spp., Arrhenatherum elatius and Holcus lanatus, Glutaraldehyde-modified | 2.16.840.1.113883.3.6905.2
0‑L | 300000034814 | L-lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysyl-L-valyl-L-phenylalanylglycyl-L-isoleucyl-L-glutamyl-L-leucyl-L-methionyl-L-glutamyl-L-valyl-L-aspartyl-L-prolyl-L-isoleucylglycyl-L-histidyl-L-leucyl-L-tyrosyl-L-isoleucyl-L-phenylalanyl-L-alanyl-L-threonine | 2.16.840.1.113883.3.6905.2
0‑L | 300000054886 | N-Acetyl-D-tyrosylglycyl-D-arginyl-D-lysyl-D-lysyl-D-arginyl-D-arginyl-D-glutaminyl-D-arginyl-D-arginyl-D-arginylglycyl-D-lysyl-D-threonyl-D-leucyl-D-arginyl-D-valyl-D-alanyl-D-lysyl-D-alanyl-D-isoleucyl-D-tyrosyl-D-lysyl-D-arginyl-D-tyrosyl-D-isoleucyl-D-alfa-glutamine acetate | 2.16.840.1.113883.3.6905.2
0‑L | 300000050583 | Gln-Gly-Pro-Pro-Leu-Met-Ala-Thr-Gln-Ser-Cys-Cys-Phe-Ala-Tyr-Ile-Ala-Arg-Pro-Leu-Pro-Arg-Ala-His-Ile-Lys-Glu-Tyr-Phe-Tyr-Thr-Ser-Gly-Lys-Cys-Ser-Asn-Pro-Ala-Val-Val-Phe-Val-Thr-Arg-Lys-Asn-Arg-Gln-Val-Cys-Ala-Asn-Pro-Glu-Lys-Lys-Trp-Val-Arg-Glu-Tyr-Ile-Asn-Ser-Leu-Glu-Met-Ser | 2.16.840.1.113883.3.6905.2
0‑L | 100000139311 | EXTRACTUM COMPOSITUM (1:1,3-1,6) EX: AGROPYRI RHIZOMATE 12,5 P.,ALLII CEPAE SQUAMA 5,0 P.,BETULAE FOLIO 10,0 P.,FOENUGRAECI SEMINE 15,0 P.,PETROSELINI RADICE 17,5 P.,SOLIDAGINIS HERBA 5,0 P., EQUISETI HERBA 10,0 P.,LEVISTICI RADICE 10,0 P.,POLYGONI AVICULARIS HERBA 15,0 P. | 2.16.840.1.113883.3.6905.2
0‑L | 300000054040 | Liquid extract (DER 1:27,6-30,4) from roselle, carrot, couch grass rhizome, yarrow, angelica archangelica root, equisetum stem, ribwort plantain, juniper, chicory root, bitter orange epicarp and mesocarp (3:2,3:2,3:2,3:1,15:1,15:1,15:1,15:1:0,64), Extraction solvent: water | 2.16.840.1.113883.3.6905.2
0‑L | 300000052018 | (12M)-(1S,2S)-N-((63S,4S,Z)-11-ethyl-12-(2-((S)-1-methoxyethyl)-5-(4-methylpiperazin-1-yl)pyridin-3-yl)-10,10-dimethyl-5,7-dioxo-61,62,63,64,65,66-hexahydro-11H-8-oxa-2(4,2)-thiazola-1(5,3)-indola-6(1,3)-pyridazinacycloundecaphane-4-yl)-2-methylcyclopropane-1-carboxamide | 2.16.840.1.113883.3.6905.2
0‑L | 300000004600 | N-Acetyl-D-tyrosylglycyl-D-arginyl-D-lysyl-D-lysyl-D-arginyl-D-arginyl-D-glutaminyl-D-arginyl-D-arginyl-D-arginylglycyl-D-lysyl-D-threonyl-D-leucyl-D-arginyl-D-valyl-D-alanyl-D-lysyl-D-alanyl-D-isoleucyl-D-tyrosyl-D-lysyl-D-arginyl-D-tyrosyl-D-isoleucyl-D-alfa-glutamine | 2.16.840.1.113883.3.6905.2
0‑L | 100000177278 | N-epsilon-palmitoyl-L-lysyl-N-epsilon-palmitoyl-L-lysyl-L-aspartyl-L-alanyl-L-glutamyl-L-phenylalanyl-L-arginyl-L-histidyl-L-aspartyl-L-seryl-glycyl-L-tyrosyl-L-glutamyl-L-valyl-L-histidyl-L-histidyl-L-glutaminyl-N-epsilon-palmitoyl-L-lysyl-N-epsilon-palmitoyl-L-lysine | 2.16.840.1.113883.3.6905.2
0‑L | 100000133591 | PLANT POLLEN ALLERGENS MIXTURE: SECALE CEREALE, AGROSTIS ALBA, ALOPECURUS PRATENSIS, ANTHOXANTHUM ODORATUM, APERA SPICA VENTI, ARRHENATHERUM ELATIUS, CYNOSURUS CRISTATUS, DACTYLIS GLOMERATA, FESTUCA PRATENSIS, HOLCUS LANATUS, LOLIUM PERENNE, PHLEUM PRATENSE, POA SP. | 2.16.840.1.113883.3.6905.2
0‑L | 100000141958 | LIQUID EXTRACT (1:28,2) FROM: HIBISCUS FLOWER, BITTER FENNEL FRUITS, CARROTS, COUCH GRASS RHIZOME, YARROW, ANGELICA ROOT, EQUISETUM STEM, RIBWORT PLANTAIN, JUNIPER, CHICORY, BITTER ORANGE PEEL (3:2,3:2,3:2,3:2,3:1,15:1,15:1,15:1,15:1:0,64), EXTRACTION SOLVENT: WATER | 2.16.840.1.113883.3.6905.2
0‑L | 300000053858 | Methyl(3as,4r,5ar,10br,13ar)-4-(acetyloxy)-3,5-epoxy-3a-ethyl-9-[(6r,8s)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methano-2h-azacyclodecino[4,3-b]indol-8-yl]-8-methoxy-6-methyl-3a,4,5,5a,6,11,12,13a-octahydro-3h-indolizino[8,1-cd]carbazole-5-carboxylate | 2.16.840.1.113883.3.6905.2
0‑L | 300000042372 | [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-Acetyloxy-12-(cyclopropanecarbonyloxy)-15-[(2R,3R)-3-(furan-2-yl)-2-hydroxy-3-(2-methylpropoxycarbonylamino)propanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate | 2.16.840.1.113883.3.6905.2
0‑L | 300000042520 | [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-12-acetyloxy-1,9-dihydroxy-15-[(2R,3S)-2-hydroxy-4,4-dimethyl-3-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoyl]oxy-4-methoxycarbonyloxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate | 2.16.840.1.113883.3.6905.2
0‑L | 300000042539 | (2S,3R)-2-acetamido-3-hydroxy-N-[(2R)-3-hydroxy-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]propan-2-yl]butanamide | 2.16.840.1.113883.3.6905.2
0‑L | 100000183927 | ADENOVIRAL VECTOR OF SEROTYPE 5 MODIFIED TO CONTAIN A CHIMERIC SEQUENCE CONSISTING OF A MINIMAL UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR PROMOTER PRECEDED BY THREE NOTCH-RESPONSIVE ELEMENTS, AND COATED WITH OLIGOPEPTIDE END-MODIFIED POLY (BETA-AMINO) ESTERS | 2.16.840.1.113883.3.6905.2
0‑L | 300000034815 | L-lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysyl-L-lysyl-L-tyrosyl-L-leucyl-L-alanyl-L-methionyl-L-prolyl-L-phenylalanyl-L-alanyl-L-threonyl-L-prolyl-L-methionyl-L-glutamyl-L-alanyl-L-glutamyl-L-leucyl-L-alanyl-L-arginyl-L-arginyl-L-seryl-L-leucyl-L-alanine acetate salt | 2.16.840.1.113883.3.6905.2
0‑L | 100000183759 | REFINED AND QUANTIFIED DRY EXTRACT OF GINKGO BILOBA DRIED LEAF (35-67:1), CORRESPONDING TO 13,2–16,2 MG OF FLAVONOIDS EXPRESSED AS FLAVONE GLYCOSIDES, 1,68–2,04 MG OF GINKGOLIDES A, B AND C, 1,56–1,92 MG OF BILOBALIDE, EXTRACTION SOLVENT: ETHANOL 59-65% (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 100000145401 | PREPARATION OF FRESH HERB OF SYMPHYTUM X UPLANDICUM (40% OF PRESSED JUICE OF FRESH HERB OF SYMPHYTUM X UPLANDICUM, DER 3-8:1, AND 60% OF AN EXTRACT OF THE PRESS RESIDUE FROM FRESH HERB OF SYMPHYTUM X UPLANDICUM, DER 3-10:1, EXTRACTION MEDIUM ETHANOL 30% V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000014580 | Grass pollen allergen extract from Agrostis tenuis, Alopecurus pratensis, Anthoxanthum odoratum, Arrhenatherum elatius, Bromus inermis, Cynosurus cristatus, Dactylis glomerata, Festuca pratensis, Holcus lanatus, Lolium perenne, Phleum pratense, Poa pratensis | 2.16.840.1.113883.3.6905.2
0‑L | 300000032753 | (1S,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E)-33-(((2S,3S,4S,6R)-4-amino-3,5-dihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-1,3,4,7,9,11,17,37-octahydroxy-15,16,18,36-tetramethyl-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaen-13-one | 2.16.840.1.113883.3.6905.2
0‑L | 300000044086 | 5-[4-[(2S,5S,11S,14R)-14-benzyl-11-(carboxymethyl)-5-[3-(diaminomethylideneamino)propyl]-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]butylamino]-2-[4,7-bis(carboxymethyl)-1,4,7-triazonan-1-yl]-5-oxopentanoic acid radioallebled with gallium-68 | 2.16.840.1.113883.3.6905.2
0‑L | 300000008772 | Refined and quantified dry extract of ginkgo biloba dried leaf (35-67:1), corresponding to 52,8–64,8 mg of flavonoids expressed as flavone glycosides, 6,72–8,16 mg of ginkgolides a, b and c, 6,24–7,68 mg of bilobalide, extraction solvent: acetone 60% (M/M) | 2.16.840.1.113883.3.6905.2
0‑L | 300000004101 | Adeno-associated viral vector serotype 8 containing the 3'-coding sequence of the mutated DnaE intein from Synechocystis sp. fused to the CEP290 body of the gene coding sequence and fused to the 5'-coding sequence of DnaB intein from Rhodothermus marinus | 2.16.840.1.113883.3.6905.2
0‑L | 300000015285 | Refined and quantified dry extract of ginkgo biloba leaves (35-67:1) quantified to 22.0 to 27.0 % of flavonoids expressed as flavone glycosides, 2.8 to 3.4 % of ginkgolides a, b and c, and 2.6 to 3.2 % of bilobalide. extraction solvent: acetone 60% (m/m) | 2.16.840.1.113883.3.6905.2
0‑L | 300000042900 | Clostridium botulinum A, strain CBAM0804 Hall-A, nontoxic-nonhaemagglutinin subunit fused to neurotoxin heavy chain fused to neurotoxin light chain fused to haemagglutinin 3b fused to haemagglutinin 1 fused to haemagglutinin 3a fused to haemagglutinin 2 | 2.16.840.1.113883.3.6905.2
0‑L | 300000040031 | Preparation of Symphytum officinale herb (DER 0.2 – 0.9 : 1), composed of 0.4 g of pressed juice from dried Symphytum officinale herb and 0.6 g of extract from the press residue of dried Symphytum officinale herb, Extraction solvent: ethanol 30% (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 100000183970 | (S)-2-isobutyrylamino-pentanedioic acid 5-amide 1-{[(2s,5s,8s,11r,12s,15s,18s,21r)-2,8-bis-((S)-sec-butyl)-21-hydroxy-5-(4-hydroxy-benzyl)-15-isobutyl-4,11-dimethyl-3,6,9,13,16,22-hexaoxo-10-oxa-1,4,7,14,17-pentaaza-bicyclo[16.3.1]docos-12-yl]-amide} | 2.16.840.1.113883.3.6905.2
0‑L | 300000053934 | (2S)-N-[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-3-[[(2S)-1-(4-aminophenyl)-3-azidopropan-2-yl]amino]-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl]-3-methoxy-5-methyl-1-oxoheptan-4-yl]-2-[[(2S)-2-(dimethylamino)-3-methylbutanoyl]amino]-N,3-dimethylbutanamide | 2.16.840.1.113883.3.6905.2
0‑L | 100000142687 | QUERCUS ROBUR/PETRAEA E CORTICE CUM CALCIO CARBONICO = D6 SOLUTION (PREPARED FROM QUERCUS ROBUR/PETRAEA E CORTICE, DECOCTUM Ø (HAB VS.23A) BY 5 MALIGE EXPONENTIATION WITH SATURATED AQUEOUS SOLUTION OF CALCIUM CARBONICA E CINERE QUERCUS) (HAB, SV5B) | 2.16.840.1.113883.3.6905.2
0‑L | 300000011940 | Refined and quantified dry extract from ginkgo leaf (35-67:1), 80 mg corresponding to 17,6-21,6 mg of flavonoids expressed as flavone glycosides, 2,2-2,7 mg of ginkgolides A, B and C, 2,1-2,6 mg of bilobalide, extraction solvent: acetone 60% (M/M) | 2.16.840.1.113883.3.6905.2
0‑L | 300000041500 | (3R,20r,24R,28S,34z,36S,38R,41S)-N-(cyclopropylsulfonyl)-9-methoxy-26,40,42-trioxo-4,25-dioxa-1,6,13,27,39-pentaazaheptacyclo(26.13.1.1(sup 3,41).0(sup 5,14).0(sup 7,12).0(sup 20,24).0(sup 36,38))tritetraconta-5,7,9,11,13,34-hexaene-38-carboxamide | 2.16.840.1.113883.3.6905.2
0‑L | 300000037819 | Refined and quantified dry extract of ginkgo leaf (35-67:1), corresponding to 17,6–21,6 mg of flavonoids expressed as flavone glycosides, 2,24–2,72 mg of ginkgolides A, B and C, 2,08–2,56 mg of bilobalide, Extraction solvent: ethanol 59-65% (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000041017 | 1-((E)-4-((E)-5-carbamoyl-2-((1-ethyl-3-methyl-1H-pyrazole-5-carbonyl)imino)-7-methoxy-2,3-dihydro-1H-benzo[d]imidazol-1-yl)but-2-en-1-yl)-2-(1-ethyl-3-(methyl)-1H-pyrazole-5-carboxamido)-7-(3-morpholinopropoxy)-1H-benzo[d]imidazole-5-carboxamide | 2.16.840.1.113883.3.6905.2
0‑L | 300000041467 | Methyl N-[(2S)-1-[(2S)-4,4-difluoro-2-[5-[4-[2-[(5R)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-3,3-dimethyl-1,3-azasilolidin-5-yl]-3H-benzo[e]benzimidazol-7-yl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate | 2.16.840.1.113883.3.6905.2
0‑L | 300000048053 | Extract of lysates from Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus sanguinis, Streptococcus pyogenes, Klebsiella pneumoniae ssp. pneumoniae, Klebsiella pneumoniae ssp. ozaenae, Staphylococcus aureus and Moraxella catarrhalis | 2.16.840.1.113883.3.6905.2
0‑L | 300000034960 | Refined and quantified dry extract of ginkgo leaf (35-67:1), corresponding to 26,4–32,4 mg of flavonoids expressed as flavone glycosides, 3,36–4,08 mg of ginkgolides A, B and C, 3,12–3,84 mg of bilobalide, Extraction solvent: acetone 60% (M/M) | 2.16.840.1.113883.3.6905.2
0‑L | 100000142693 | QUERCUS ROBUR/PETRAEA E CORTICE CUM CALCIO CARBONICO DIL. D12 AQUOS. (HAB, SV5B: SOLN=D6 PRODUCED BY 5 MALIGE POTENTIATION OF QUERCUS ROBUR/PETRAEAE CORTICE, DECOCTUM Ø (HAB VS.23A) WITH SATURATED AQUEOUS SOLUTION OF CALCAREAE CINERE QUERCUS) | 2.16.840.1.113883.3.6905.2
0‑L | 300000037378 | Refined and quantified dry extract from ginkgo leaf (35-67:1), quantified to 17,6-21,6 mg of flavonoids expressed as flavone glycosides, 2,08-2,56 mg of bilobalide, 2,24-2,72 mg of ginkgolides a, b and c, Extraction solvent: acetone 60% (M/M) | 2.16.840.1.113883.3.6905.2
0‑L | 300000039140 | Refined and quantified dry extract from Ginkgo leaf (35-67:1), corresponding to 23.1- 28.4 mg of flavonoids expressed as flavone glycosides, 2.9-3.6 mg of ginkgolides A, B and C, 2.7-3.4 mg of bilobalide, Extraction solvent: acetone 60% M/M | 2.16.840.1.113883.3.6905.2
0‑L | 100000168633 | GINKGO DRY EXTRACT (35-67:1), REFINED AND QUANTIFIED 80 MG CORRESPONDING TO: 17,6-21,6 MG OF FLAVONOIDS EXPRESSED AS FLAVONE GLYCOSIDES, 2,2-2,7 MG OF GINKGOLIDES A, B AND C, 2,1-2,6 MG OF BILOBALIDE, EXTRACTION SOLVENT: ACETONE 65% (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000056177 | Soft extract of dry raw pollen from Secale cereale, Phleum pratense and Zea mays (30:1.5:1), DER genuine 12-28: 1, First extraction solvent: water, acetone, sodium laurilsulfate (27:1:0.01 w/w/w), Second extraction solvent: acetone (100%) | 2.16.840.1.113883.3.6905.2
0‑L | 100000139510 | EXTRACTUM COMPOSITUM EX: VALERIANA OFFICINALIS L., RADIX - 5 P.: MELISSA OFFICINALIS L., HERBA - 5 P.: ARCHANGELICA OFFICINALIS HOFFM., RADIX – 4 P.: HUMULUS LUPULUS L., STROBILUS – 3 P.: LAVANDULA OFFICINALIS CHAIX EX VILLARS, FLOS -3 P | 2.16.840.1.113883.3.6905.2
0‑L | 100000183099 | VACCINIA VIRUS STRAIN ANKARA-BAVARIAN NORDIC-BRACHYURY CO-EXPRESSING THE BRACHYURY HUMAN TUMOR-ASSOCIATED ANTIGEN, THE HUMAN LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-3, THE HUMAN INTERCELLULAR ADHESION MOLECULE 1 AND THE HUMAN CD80 ANTIGEN | 2.16.840.1.113883.3.6905.2
0‑L | 300000052139 | (2S)-2-((2-amino-2-methyl-propanoyl)amino)-N-((1S,2R)-2-methoxy-4-((2S)-2-((1R,2R)-1-methoxy-2-methyl-3-oxo-3-(((1S)-2-phenyl-1-thiazol-2-yl-ethyl)amino)propyl)pyrrolidin-1-yl)-1-((1S)-1-methylpropyl)-4-oxo-butyl)-N,3-dimethyl-butanamide | 2.16.840.1.113883.3.6905.2
0‑L | 300000047578 | [(1S,4S,6R,14S,18R)-18-[8-Chloro-7-methoxy-2-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]quinolin-4-yl]oxy-14-(cyclopentyloxycarbonylamino)-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadecan-4-yl]-[(2,6-difluorophenyl)methyl]phosphinic acid | 2.16.840.1.113883.3.6905.2
0‑L | 100000131454 | LYOPHILIZED BACTERIAL LYSATES OF: HAEMOPHILUS INFLUENZAE STREPTOCOCCUS (DIPLOCOCCUS) PNEUMONIAE KLEBSIELLA PNEUMONIAE AND OZAENAE STAPHYLOCOCCUS AUREUS STREPTOCOCCUS PYOGENES AND VIRIDANS MORAXELLA (BRANHAMELLA / NEISSERIA) CATARRHALIS | 2.16.840.1.113883.3.6905.2
0‑L | 300000010520 | Modified Vaccinia Ankara - Bavarian Nordic virus encoding the Ebola virus Zaire Mayinga strain glycoprotein, the Ebola virus Sudan strain glycoprotein, the Marburg virus Musoke strain glycoprotein and the Taï Forest virus nucleoprotein | 2.16.840.1.113883.3.6905.2
0‑L | 300000011742 | Gly-Leu-Ala-Gly-Gly-Ser-Ala-Gln-Ser-Gln-Arg-Ala-Pro-Asp-Arg-Val-Leu-Cys-His-Ser-Gly-Gln-Gln-Gln-Gly-Leu-Pro-Arg-Ala-Ala-Gly-Gly-Ser-Val-Pro-His-Pro-Arg-Cys-Lys-Ile-Ser-Ile-Thr-Glu-Ile-Lys-Gly-Val-Ile-Val-His-Arg-Ile-Glu-Thr-Ile-Leu-Phe | 2.16.840.1.113883.3.6905.2
0‑L | 300000013341 | Refined and quantified Ginkgo dry extract (35-67:1), corresponding to 8.80-10.80 mg of flavonoids expressed as flavone glycosides, 1.12-1.36 mg of ginkgolides A, B and C, 1.04-1.28 mg of bilobalide, extraction solvent: acetone 60% M/M | 2.16.840.1.113883.3.6905.2
0‑L | 100000139612 | EXTRACTUM COMPOSITUM (1 : 1-1,2) EX: HIPPOCASTANI SEMINE – 27 P., BETAE ESCULENTA RADICE – 19 P., TILIAE FLORE – 15 P., FAGOPYRI HERBA – 12 P., CRATAEGI FOLIO CUM FLORE – 11 P., SOLIDAGINIS HERBA – 4 P.: EKSTRAHENT – ETANOL 60% (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000047919 | RNA (recombinant 5'-(m7G-5'-> 5')-ppp-Gm)-capped all uridine->N1-methylpseudouridine-substituted patient-specific neoantigen-specifying plus 5'-and 3'-untranslated flanking region-containing poly(A)-tailed messenger mRNA), inner salt | 2.16.840.1.113883.3.6905.2
0‑L | 100000166057 | DISTILLATE OF LEMON BALM LEAVES, SAGE LEAVES, ROSEMARY LEAVES, THYME LEAVES, ANGELICA ROOT, NUTMEG SEEDS, CINNAMON, CLOVES AND LEMON (1: 0.125: 0.1: 0.083: 0.067: 0.042: 0.033: 0.017: 0.008), DISTILLATION AGENT: ETHANOL 70% (V / V) | 2.16.840.1.113883.3.6905.2
0‑L | 100000175579 | Methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(8S)-7-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-1,4-dioxa-7-azaspiro[4.4]nonan-8-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate | 2.16.840.1.113883.3.6905.2
0‑L | 300000034678 | Humanised IgG1 monoclonal antibody against BCMA conjugated to 20-methyl-1-(3-methyl-3,9-dihydro-8H-dibenzo[b,f][1,2,3]triazolo[4,5-d]azocin-8-yl)-1,5,21- trioxo-8,11,14,17-tetraoxa-4,20-diazapentacosan-25-oyl desacetyl maytansinoid | 2.16.840.1.113883.3.6905.2
0‑L | 300000042919 | Clostridium botulinum A, nontoxic-nonhaemagglutinin subunit fused to neurotoxin heavy chain fused to neurotoxin light chain fused to haemagglutinin 50 fused to haemagglutinin 33 fused to haemagglutinin 20 fused to haemagglutinin 17 | 2.16.840.1.113883.3.6905.2
0‑L | 300000044090 | DNA, D(P-thio)((2'-o-(2-methoxyethyl))RG-(2'-O-(2-methoxyethyl))RG-(2'-O-(2-methoxyethyl))m5ru-t-m5c-m5c-m5c-g-a-g-g-t-g-(2'-O-(2-methoxyethyl))m5rc-(2'-O-(2-methoxyethyl))m5rc-(2'-O-(2-methoxyethyl))m5rc-(2'-O-(2-methoxyethyl))ra) | 2.16.840.1.113883.3.6905.2
0‑L | 300000049697 | [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-12-Acetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-4-methoxycarbonyloxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate | 2.16.840.1.113883.3.6905.2
0‑L | 100000170413 | SOFT EXTRACT OF DRIED CRUDE POLLEN FROM SECALE CEREALE, PHLEUM PRATENSE AND ZEA MAYS (30:1.5:1), DER: 12–28:1, FIRST EXTRACTION SOLVENT: WATER: ACETONE : SODIUM LAURILSULFATE (96:4:0.022 M/M/M), SECOND EXTRACTION SOLVENT: ACETONE | 2.16.840.1.113883.3.6905.2
0‑L | 100000145019 | AQUEOS EXTRACT (1:15,6) FROM 2,5 G FROM A MIXTURE OF HAWTHORN LEAF AND FLOWER, VALERIAN ROOT, MELISSA LEAF, MISTLETOE, HOPS STROBILE, ROSEMARY LEAF, BITTER ORANGE PEEL, LAVENDER FLOWER (7:4:4:3:2:2:2:1), EXTRACTION LIQUID: WATER | 2.16.840.1.113883.3.6905.2
0‑L | 100000159582 | DISTILLATE OF CARAWAY OIL, LAUREL OIL, CLOVE OIL, FENNEL OIL, ANISE OIL, EUCALYPTUS OIL, CINNAMON OIL, CAMPHOR, LEVOMANTHOL (12,07 : 1,32 : 10,11 : 9,58 : 4,89 : 2,42 : 1 : 6,53 : 4,05): DISTILLATION LIQUID: ETHANOL 47,5 % (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000050326 | (2R)-2-[[(2S)-2-[[(2R)-2-[(2R,3R,4R,5S,6R)-3-Acetamido-5-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoyl]amino]propanoyl]amino]-5-amino-5-oxopentanoic acid | 2.16.840.1.113883.3.6905.2
0‑L | 300000042373 | [2-methoxy-4-[(E)-3-(4-nitrooxybutoxy)-3-oxoprop-1-enyl]phenyl] (4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate | 2.16.840.1.113883.3.6905.2
0‑L | 100000169108 | DISTILLATE OF CINNAMON BARK, LEMON PEEL, CLOVE, ALLSPICE FRUIT, CARDAMOM SEED, JUNIPER BERRY, ANGELICA ROOT, GINGER ROOT, MELISSA LEAF, MACE (4 : 40 : 1,5 : 3 : 1 : 14 : 6 : 5 : 6 : 0,5), DISTILLATION AGENT: ETHANOL 78 % (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000027893 | 2-(3-{1-[1-(4-{[6-Amino-8-hydroxy-2-(2-methoxyethoxy)-9Hpurin-9-yl]methyl}phenyl)-1-oxo-5,8,11,14,17,20,23,26,29,32-decaoxa-2-azatetratriacontan-34-yl]-1H-1,2,3triazole-4-yl}propanamido)ethyl 2,3-Bis(oleoyloxy)propyl phosphate | 2.16.840.1.113883.3.6905.2
0‑L | 300000041343 | N-[[(6aS,7R,13S,14S,16R)-5-(acetyloxy)-6,6a,7,13,14,16-hexahydro-8,14-dihydroxy-9-methoxy-4,10,17-trimethyl-7,13-imino-12H-1,3-dioxolo[7,8]isoquino[3,2-b][3]benzazocin-16-yl]methyl]-3-[3-(trifluoromethyl)phenyl]-2E-propenamide | 2.16.840.1.113883.3.6905.2
0‑L | 300000042682 | [(3S)-1-[[(2R,3R,4R,5S,6R)-2-[[(2R,3S,4R,5R,6R)-3,4-dihydroxy-5-[[(3R)-3-hydroxytetradecanoyl]amino]-6-phosphonooxyoxan-2-yl]methoxy]-4-hydroxy-6-(hydroxymethyl)-5-phosphonooxyoxan-3-yl]amino]-1-oxotetradecan-3-yl] dodecanoate | 2.16.840.1.113883.3.6905.2
0‑L | 300000048061 | Immunoglobulins against Escherichia coli, Salmonella dublin, Salmonella enteritidis, Salmonella typhimurium, Salmonella rostock, Salmonella abortusequi, Streptococcus pneumoniae, Streptococcus equi subsp. zooepidemicus, Equine | 2.16.840.1.113883.3.6905.2
0‑L | 300000052035 | 2-((S)-4-((S)-7-(3-Amino-2-fluoro-5-methyl-6-(trifluoromethyl)phenyl)-2-(((2r,7as)-2-fluorotetrahydro-1h-pyrrolizin-7a(5h)-yl)methoxy)-7,8-dihydro-5h-pyrano(4,3-d)pyrimidin-4-yl)-1-(2-fluoroacryloyl)piperazin-2-yl)acetonitrile | 2.16.840.1.113883.3.6905.2
0‑L | 100000170041 | DISTILLATE (1 : 12) FROM PEPPERMINT LEAF, ANISEED, LAVENDER FLOWER, BITTER FENNEL FRUIT, SAGE LEAF, WORMWOOD, CENTAURY, ELECAMPANE RHIZOME (8,33 : 5 : 5 : 3,33 : 1,67 : 1,67 : 1,67 : 1), DISTILLATION AGENT: ETHANOL 34 % (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000042058 | N-[(2R)-1-[(2S)-2-[(3-hydroxy-2-methyl-6-{[(3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl]oxy}oxan-4- yl)carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]pyridine-4-carboxamide | 2.16.840.1.113883.3.6905.2
0‑L | 300000042371 | (4aS,6aR,6aR,6bR,8aR,12aR,14bS)-6a-[[(E)-3-[2-[[(E)-3-carboxyprop-2-enoyl]amino]-5-hydroxyphenyl]prop-2-enoyl]oxymethyl]-2,2,6b,9,9,12a-hexamethyl-10-oxo-3,4,5,6,6a,7,8,8a,11,12,13,14b-dodecahydro-1H-picene-4a-carboxylic acid | 2.16.840.1.113883.3.6905.2
0‑L | 300000042779 | L-Lysylglycyl-L-isoleucyl-L-methionyl-L-lysyl-L-glutamyl-L-lysyl-L-lysyl-L-seryl-L-leucyl-L-valyl-L-arginyl-L-leucyl-L-seryl-L-seryl-L-cysteinyl-L-valyl-L-prolyl-L-valyl-L-alanyl-L-leucyl-L-methionyl-L-seryl-L-alanine acetate | 2.16.840.1.113883.3.6905.2
0‑L | 100000158061 | EXTRACTUM SICCUM COMPOSITUM (4- 9 : 1) EX BAPTISIAE TINCTORIAE L. RADIX 4,92 P., ECHINACEAE PURPUREAE (L.) MOENCH RADIX 1,85 P., ECHINACEAE PALLIDAE NUTT. RADIX 1,85 P., THUJAE OCCIDENTALIS L. HERBA 1 P., ETHANOL 30 % (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000045868 | Dry extract refined from Birch bark, equivalent to 0.5-1.0 g birch bark, including 84-95 mg triterpenes calculated as the sum of betulin, betulinic acid, erythrodiol, lupeol and oleanolic acid, Extraction solvent: n-heptane | 2.16.840.1.113883.3.6905.2
0‑L | 100000181070 | (S)-10-[(dimethylamino)methyl]-4-ethyl-9-hydroxy-4-o-[alpha-(2'', 4'', 5'', 7''-tetranitro-9''-fluorenylideneaminooxy)propionyl]-1h-pyrano[3', 4', 6', 7']indolizino[1,2-beta]-quinoline-3, 14-(4h), 12h)-dione, hydrochloride | 2.16.840.1.113883.3.6905.2
0‑L | 300000008826 | [4-aminobutanoic acid-glycyl-L-glutaminyl-L-arginyl-L-.alpha.-glutamyl-L-threonyl-L-prolyl-L-.alpha.-glutamylglycyl-L-alanyl-L-.alpha.-glutamyl-L-alanyl-L-lysyl-L-prolyl-L-tryptophyl-L-tyrosyl-L-aspartyl](cyclo 1-Dgamma17) | 2.16.840.1.113883.3.6905.2
0‑L | 300000018720 | (3S,10S,14S)-1-[4-[[(2S)-4-carboxy-2-[(2S)-4-carboxy-2-(6-[18F] fluoropyridin-3-amido)butanamido]butanamido]methyl]phenyl]-3-[(naphthalen-2-yl)methyl]-1,4,12-trioxo-2,5,11,13-tetraazahexadecane-10,14,16-tricarboxylic acid | 2.16.840.1.113883.3.6905.2
0‑L | 300000052878 | [(1S,2S,3R,4S,7R,8S,9R,10S,12R,15S)-4,12-Diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,8,9-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate | 2.16.840.1.113883.3.6905.2
0‑L | 100000175246 | Methyl (15S,16R,18R)-10,23-bis(ethylsulfanylmethyl)-16-hydroxy-15-methyl-3-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1,6,8(13),9,11,20(25),21,23,26-nonaene-16-carboxylate | 2.16.840.1.113883.3.6905.2
0‑L | 300000003820 | (6S,9aS)-8-((6-(3-(4-ethyl-1-piperazinyl)-1-azetidinyl)-2-pyridinyl)methyl)-6-((2-fluoro-4-hydroxyphenyl)methyl)hexahydro-4,7-dioxo-N-(phenylmethyl)-2-(2-propen-1-yl)-2h-pyrazino(2,1-c)(1,2,4)triazine-1(6h)-carboxamide | 2.16.840.1.113883.3.6905.2
0‑L | 300000026033 | Autologous T lymphocyte-enriched population of cells transduced with a lentiviral vector encoding a chimeric antigen receptor targeting human claudin 18.2 antigen with CD28 and CD3-zeta intracellular signalling domains | 2.16.840.1.113883.3.6905.2
0‑L | 100000175616 | N-[2-(dimethylamino)ethyl]-2-{[26,27,28-tris({[2-(dimethylamino)ethyl]carbamoyl}methoxy)pentacyclo[19.3.1.1^{3,7}.1^{9,13}.1^{15,19}]octacosa-1(25),3(28),4,6,9(27),10,12,15(26),16,18,21,23-dodecaen-25-yl]oxy}acetamide | 2.16.840.1.113883.3.6905.2
0‑L | 300000042778 | L-Lysylglycyl-L-isoleucyl-L-methionyl-L-lysyl-L-glutamyl-L-lysyl-L-lysyl-L-seryl-L-leucyl-L-valyl-L-arginyl-L-leucyl-L-seryl-L-seryl-L-cysteinyl-L-valyl-L-prolyl-L-valyl-L-alanyl-L-leucyl-L-methionyl-L-seryl-L-alanine | 2.16.840.1.113883.3.6905.2
0‑L | 100000181834 | 5-(2,6-difluoro-phenoxy)-3(R,S)-(2(S)-(2(S)-(3-methoxycarbonyl-2(S)-(3-methyl-2(S)-((quinoline-2-carbonyl)-amino)-butyrylamino)-propionylamino)-3-methyl-butyrylamino)-propionylamino)-4-oxo-pentanoic acid methyl ester | 2.16.840.1.113883.3.6905.2
0‑L | 100000182408 | LIQUID EXTRACT FROM ONOPORDUM ACANTHIUM FLOWER (DSR 1:3.1), EXTRACTION SOLVENT: 99 PARTS OF ETHANOL 26% (M/M) AND 1 PART OF LIQUID EXTRACT FROM HYOSCYAMUS NIGER HERB [(DER 1:2), EXTRACTING SOLVENT: ETHANOL 86% (M/M)] | 2.16.840.1.113883.3.6905.2
0‑L | 300000032600 | (S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethylcarbamoyl)-quinolin-6-yl)(methyl)amino)-propyl)piperazin-1-yl)-2-oxoethyl)-68Ga-[1,4,7,10]-tetraazacyclododecane-1,4,7-triyl)triacetate | 2.16.840.1.113883.3.6905.2
0‑L | 100000139507 | EXTRACTUM COMPOSITUM (ET. 96% V/V, 1:7,5) EX: SOENI, SALICIS CORTICE, POLYGONI AVICULARIS HERBA, EQUISETI HERBA, MILLEFOLII HERBA, CHAMOMILLAE ANTHODIO, CALENDULAE ANTHODIO, SAPONARIAE RADICE (25:10:4:4:2:2:1,5:1,5) | 2.16.840.1.113883.3.6905.2
0‑L | 300000010761 | 2-((3-((4-((3-aminopropyl)amino)butyl)amino)propyl)amino)-N-((5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl)acetamide, tetrahydrochloride | 2.16.840.1.113883.3.6905.2
0‑L | 300000054163 | 2-[4,7-Bis(carboxymethyl)-10-[2-[4-[3-[[4-[[2-[(2S)-2-cyano-4,4-difluoropyrrolidin-1-yl]-2-oxoethyl]carbamoyl]quinolin-6-yl]-methylamino]propyl]piperazin-1-yl]-2-oxoethyl]-1,4,7,10-tetrazacyclododec-1-yl]acetic acid | 2.16.840.1.113883.3.6905.2
0‑L | 100000174814 | LIQUID EXTRACT FROM A MIXTURE (4.7:1) OF MATRICARIA CAPITULA AND RAY FLORETS (DER 1:4.0-4.5), EXTRACTION SOLVENTS: ETHANOL 96% (V/V), PURIFIED WATER, SODIUM ACETATE TRIHYDRATE, SODIUM ASCORBATE AND SODIUM HYDROXIDE | 2.16.840.1.113883.3.6905.2
0‑L | 100000175117 | (1S,4R,6S,7E,18S)-18-[7-Methoxy-8-methyl-2-[4-(trifluoromethyl)-1,3-thiazol-2-yl]quinolin-4-yl]oxy-13-methyl-N-(1-methylcyclopropyl)sulfonyl-2,14-dioxo-3,13,15-triazatricyclo[13.4.0.04,6]nonadec-7-ene-4-carboxamide | 2.16.840.1.113883.3.6905.2
0‑L | 300000021703 | Refined and quantified dry extract from Vaccinium macrocarpon fruit juice (20-35:1), corresponding to 36 mg (34.2-37.8 mg) of proanthocyanidins expressed as proanthocyanidins A2, extraction solvent: ethanol 70% V/V | 2.16.840.1.113883.3.6905.2
0‑L | 300000041389 | Cyanomethyl (6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(2,2,3,3-tetramethylcyclopropanecarbonyl)oxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carboxylate | 2.16.840.1.113883.3.6905.2
0‑L | 300000050600 | (2S,5S,6S)-2-[(S)-[(2S,3R,4S,5R)-5-(Aminomethyl)-3,4-dihydroxyoxolan-2-yl]oxy-[(2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-6-hydroxy-1,4-dimethyl-3-oxo-1,4-diazepane-5-carboxylic acid | 2.16.840.1.113883.3.6905.2
0‑L | 300000024246 | 17-chloro-5,13,14,22-tetramethyl-28-oxa-2,9-dithia-5,6,12,13,22-pentazaheptacyclo[27.7.1.14,7.011,15.016,21.020,24.030,35]octatriaconta-1(36),4(38),6,11,14,16,18,20,23,29(37),30,32,34-tridecaene-23-carboxylic acid | 2.16.840.1.113883.3.6905.2
0‑L | 100000133323 | GRASS POLLEN ALERGOIDS MIXTURE: ALOPECURUS PRATENSIS, ANTHOXANTHUM ODORATUM, ARRHENATHERUM ELATIUS, DACTYLIS GLOMERATA, FESTUCA PRATENSIS, HOLCUS LANATUS, LOLIUM PERENNE, PHLEUM PRATENSE, POA SP., SECALE CEREALE | 2.16.840.1.113883.3.6905.2
0‑L | 100000174755 | EXTRACT (1:12.4) OF HAWTHORN LEAF AND FLOWER, VALERIAN ROOT, MELISSA LEAF, MISTLETOE, HOP STROBILE, ROSEMARY LEAF, BITTER-ORANGE EPICARP AND MESOCARP, LAVENDER FLOWER (7:4:4:3:2:2:2:1), EXTRACTION SOLVENT: WATER | 2.16.840.1.113883.3.6905.2
0‑L | 100000183100 | FOWLPOX VIRUS STRAIN TBC-FPV CO-EXPRESSING THE BRACHYURY HUMAN TUMOR-ASSOCIATED ANTIGEN, THE HUMAN LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-3, THE HUMAN INTERCELLULAR ADHESION MOLECULE 1 AND THE HUMAN CD80 ANTIGEN | 2.16.840.1.113883.3.6905.2
0‑L | 300000048802 | (2S)-5-(Diaminomethylideneamino)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-2,5-diamino-5-oxopentanoyl]amino]pentanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]amino]pentanoic acid | 2.16.840.1.113883.3.6905.2
0‑L | 100000182409 | LIQUID EXTRACT FROM PRIMULA VERIS FLOWER (DSR 1:3.1), EXTRACTION SOLVENT: 99 PARTS OF ETHANOL 26% (M/M) AND 1 PART OF LIQUID EXTRACT FROM HYOSCYAMUS NIGER HERB [(DER 1:2), EXTRACTING SOLVENT: ETHANOL 86% (M/M)] | 2.16.840.1.113883.3.6905.2
0‑L | 100000184027 | DRY EXTRACT (DER 3-6:1) FROM GINSENG ROOT, ATRACTYLODES LANCEA RHIZOME, PORIA, PINELLIA TERNATA ROOT, TANGERINE, JUJUBE FRUIT, LICORICE AND GINGER (2 : 2 : 2 : 2 : 1 : 1 : 0.5 : 0.25), EXTRACTION SOLVENT: WATER | 2.16.840.1.113883.3.6905.2
0‑L | 300000045554 | Allogeneic non-alloreactive T cells edited with mRNA to disrupt TRAC and CD52 genes and transduced with a lentiviral vector to express two chimeric antigen receptors independently directed against CD20 and CD22 | 2.16.840.1.113883.3.6905.2
0‑L | 300000051008 | Bis[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl](2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate | 2.16.840.1.113883.3.6905.2
0‑L | 300000018771 | S3,S13-cyclo(D-tyrolsyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-aspartyl-L-tryptophyl-N-methyl-L-glycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-N-methyl-L-isoleucinamide) acetate | 2.16.840.1.113883.3.6905.2
0‑L | 300000038847 | ((Trans)-4-((2-(((2-chloro-4-((((R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)carbamoyl)oxy)ethyl)(methyl)amino)cyclohexyl 2-hydroxy-2,2-di(thiophen-2-yl)acetate | 2.16.840.1.113883.3.6905.2
0‑L | 300000051768 | 1-(1-oxooctyl)-L-prolyl-L-cysteinyl-L-lysyl-L-asparaginyl-2,4,6-trimethyl-L-phenylalanyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-cysteinyl-L-lysine, (2->13)-disulfide | 2.16.840.1.113883.3.6905.2
0‑L | 100000172864 | 8-(3-((2-(4-AMINOPHENYL)-7-METHOXY-5-OXO-1,11A.BETA.-DIHYDRO-5H-PYRROLO(2,1-C)(1,4)BENZODIAZEPINE-8-YL)OXY)PROPOXY)-7-METHOXY-2-(4-METHOXYPHENYL)-1,11A.BETA.-DIHYDRO-5H-PYRROLO(2,1-C)(1,4)BENZODIAZEPINE-5-ONE | 2.16.840.1.113883.3.6905.2
0‑L | 300000043000 | Soft extract of crude pollen of Secale cereale, Phleum pratense and Zea mays (30:1.5:1), First extraction solvent: Water:acetone:sodium laurilsulfate (27:1:0.01 w/w), Second extraction solvent: acetone (100%) | 2.16.840.1.113883.3.6905.2
0‑L | 300000047577 | 1-(4-tert-butylphenyl)sulfonyl-3-[(3R)-3-[(3S,5R,6R,7R,8R,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]butyl]urea | 2.16.840.1.113883.3.6905.2
0‑L | 300000036064 | Modified vaccinia Ankara - Bavarian Nordic virus, expressing Respiratory syncytial virus glycoprotein strain A2, glycoprotein strain B, nucleocapsid protein, matrix protein, fusion protein strain Along, Live | 2.16.840.1.113883.3.6905.2
0‑L | 300000021735 | [(3As,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[[2-[(1-cyclopentylpiperidin-4-yl)amino]-1,3-benzothiazol-6-yl]sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate | 2.16.840.1.113883.3.6905.2
0‑L | 300000014040 | S-[(2R)-2,3-Dipalmitoyloxypropyl]-L-cysteinylglycyl-L-asparaginyl-L-asparaginyl-L-alpha-aspartyl-L-alpha-glutamyl-L-seryl-L-asparaginyl-L-isoleucyl-L-seryl-L-phenylalanyl-L-lysyl-L-alpha-glutamyl-L-lysine | 2.16.840.1.113883.3.6905.2
0‑L | 300000053846 | 3-[3-Bromo-4-[(2,4-difluorophenyl)methoxy]-6-methyl-2-oxopyridin-1-yl]-N-[4-[1-[4-[4-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]butylamino]-4-oxobutyl]triazol-4-yl]butyl]-4-methylbenzamide | 2.16.840.1.113883.3.6905.2
0‑L | 300000055678 | 2-{[2-({(2S)-4-carboxy-1-[4-({4-[11β-hydroxy-3,20-dioxo-21-(phosphonooxy)-2'H,16βH-[1,3]dioxolo[4',5':16,17]pregna-1,4-dien-2'αyl]phenyl}methyl)anilino]-1-oxobutan-2-yl}amino)-2-oxoethyl]amino}-2-oxoethyl | 2.16.840.1.113883.3.6905.2
0‑L | 300000039588 | Adeno-associated viral vector serotype 8 encoding B-domain deleted liver specific codon optimized bioengineered chimeric human porcine factor VIII, under a synthetic hepatic combinatorial bundle promoter | 2.16.840.1.113883.3.6905.2
0‑L | 300000043585 | Dry standardised extract from milk thistle fruit equivalent to 3325 mg – 9720 mg of milk thistle fruit corresponding to 108 mg of silymarin calculated as silibin, Extraction solvent: acetone 99.9 % (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000056648 | Liquid extract (1:11) from Marshmallow root, Chamomile flower, roman, Equisetum stem, Juglans regia leaf, Yarrow, Oak bark, Dandelion herb with root (4:3:5:4:4:2:4), Extraction solvent: ethanol 59% (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000024717 | N-carboxymethyl-glycyl-L-threonyl-L-histidyl-L-3,3-diphenylalanyl-L-piperidincarboxy-3-yl-L-arginyl-L-S-methylthio-cystyl-L-arginyl-L-tryptophyl-aminohexanyl-N-carboxamidomethyl-glycine N-hexadecylamide | 2.16.840.1.113883.3.6905.2
0‑L | 300000026911 | Allogeneic non-alloreactive T cells edited with mRNA to disrupt TRAC and CD52 genes and transduced with lentiviral vector expressing a chimeric antigen receptor against CD22 and RQR8 depletion mechanism | 2.16.840.1.113883.3.6905.2
0‑L | 300000032498 | Hop strobile oleoresin, corresponding to 3.36 g potassium hop beta acids, expressed as potassium lupulone, potassium adlupulone and potassium colupulone, Extraction solvent: supercritical carbon dioxide | 2.16.840.1.113883.3.6905.2
0‑L | 300000003598 | Dry extract from rhubarb root (30-70 parts) and rheum australe root (30-70 parts), corresponding to 4.3-5.3 mg of hydroxyanthracene derivatives, calculated as rhine, extraction solvent: ethanol 90% V/V | 2.16.840.1.113883.3.6905.2
0‑L | 300000006102 | S3,S13-cyclo(D-tyrolsyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-aspartyl-L-tryptophyl-N-methyl-L-glycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-N-methyl-L-isoleucinamide) | 2.16.840.1.113883.3.6905.2
0‑L | 300000017080 | 3-amino-N-{[5-[4-[bis[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]piperidine-1-carbonyl]-1,3-diethyl-benzimidazol-1-ium-2-yl]methyl}-5H-pyrrolo[2,3-b]pyrazine-2-carboxamide dihydrochloride chloride | 2.16.840.1.113883.3.6905.2
0‑L | 300000024245 | (2R)-2-[5-[3-Chloro-2-methyl-4-[2-(4-methylpiperazin-1-yl)ethoxy]phenyl]-6-(4-fluorophenyl)thieno[2,3-d]pyrimidin-4-yl]oxy-3-[2-[[2-[2-(hydroxymethyl)phenyl]pyrimidin-4-yl]methoxy]phenyl]propanoic acid | 2.16.840.1.113883.3.6905.2
0‑L | 300000056630 | 3-(3-carboxypropyl)-2-[2-[3-[2-[1,3-dihydro-3,3-dimethyl-1-(3-sulfopropyl)-2H-indol-2-ylidene]ethylidene]-2-(4-sulfophenoxy)-1-cyclohexen-1-yl]ethenyl]-3-methyl-1-(3-sulfopropyl)-3H-indolium inner salt | 2.16.840.1.113883.3.6905.2
0‑L | 300000008877 | (S)-10-[(dimethylamino)methyl]-4-ethyl-9-hydroxy-4-O-[alfa-(2", 4", 5", 7"-tetranitro-9"-fluorenylideneaminooxy)propionyl]-1H-pyrano[3', 4', 6', 7']indolizino[1,2-beta]-quinoline-3, 14-(4H, 12H)-dione | 2.16.840.1.113883.3.6905.2
0‑L | 300000054910 | (2R)-4-[2-[4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-ethylphenoxy]ethyl]-N-[3-[[(3R)-2,6-dioxo-3-piperidinyl]amino]phenyl]-2-methyl-1-piperazineacetamide | 2.16.840.1.113883.3.6905.2
0‑L | 100000159897 | EXTRACT (1:38) FROM MARSHMALLOW ROOT, OAK BARK, CAMOMILE FLOWERS, DANDELION HERB, HORSETAIL HERB, YARROW HERB AND WALNUT LEAVES (4:2:3:4:5:4:4), EXTRACTION SOLVENTS: ETHANOL 59% (V/V), PURIFIED WATER | 2.16.840.1.113883.3.6905.2
0‑L | 300000027196 | Liquid extract (0.67:1) from: Artemisia abrotanum herb, milk thistle fruit, peppermint leaf, Centaurea benedicta herb, dandelion root and yarrow (35/15/8/3/3/3), Extraction solvent: ethanol 70% (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000041472 | 3-((4-((4-((((5-(1,1-dimethylethyl)-2-methoxy-3-((methylsulfonyl)amino)phenyl)amino)carbonyl)amino)-1-naphthalenyl)oxy)-2-pyrimidinyl)amino)-5-ethynyl-N-(2-(2-(2-methoxyethoxy)ethoxy)ethyl)-benzamide | 2.16.840.1.113883.3.6905.2
0‑L | 100000139505 | EXTRACTUM LIQUIDUM (ET. 75% V/V, 1:2) EX: PHASEOLI PERICARPIO, BARDANAE RADICE, SAMBUCI FRUCTU, EQUISETI HERBA, RHEI RADICE, FAGOPYRI HERBA, ONONIDIS RADICE, BETULAE FOLIO ( 30:20:15:10:7,5:7,5:5:5) | 2.16.840.1.113883.3.6905.2
0‑L | 300000038210 | Turkey herpesvirus, strain HVT/IBD/ILT (cell-associated), expressing VP2 protein gene of Infectious bursal disease virus and gD and gI glycoproteins genes of Infectious laryngotracheitis virus, Live | 2.16.840.1.113883.3.6905.2
0‑L | 300000047463 | [(1S,9R,18R,19S,21R,22S)-7,7,8,12,13,22-hexahydroxy-21-(hydroxymethyl)-3,6,16-trioxo-2,17,20,23-tetraoxapentacyclo[16.3.1.18,11.04,9.010,15]tricosa-4,10,12,14-tetraen-19-yl] 3,4,5-trihydroxybenzoate | 2.16.840.1.113883.3.6905.2
0‑L | 100000175242 | (6aS)-3-[3-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-8-methylidene-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-11-one | 2.16.840.1.113883.3.6905.2
0‑L | 300000041445 | (2R)-2-(((3R)-3-(1,3-benzodioxol-5-yl)-3-(((6-methoxy-2-naphthyl)sulfonyl)amino)propanoyl)amino)-3-(4-(((2R,6S)-2,6-dimethylpiperidinyl)methyl)phenyl)-N-isopropyl-N-methylpropanamide hydrochloride | 2.16.840.1.113883.3.6905.2
0‑L | 300000041506 | Methyl N-[(1S,2S)-1-(4-chlorophenyl)-1-(3,5-difluorophenyl)-3-[[5-fluoro-4-[2-[(2R,5S)-5-(2,2,2-trifluoroethylcarbamoyloxymethyl)morpholin-2-yl]ethyl]pyridin-3-yl]amino]-3-oxopropan-2-yl]carbamate | 2.16.840.1.113883.3.6905.2
0‑L | 300000041871 | L-Aspartyl-L-leucyl-L-arginyl-L-glutaminyl-L-methionyl-L-arginyl-L-threonyl-L-valyl-L-threonyl-L-prolyl-L-isoleucyl-L-arginyl-L-methionyl-L-glutaminyl-glycyl-glycyl-L-seryl-glycyl-L-serine acetate | 2.16.840.1.113883.3.6905.2
0‑L | 300000042699 | (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-1-[[3-(2-hydroxypropan-2-yl)phenyl]methoxy]propan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol | 2.16.840.1.113883.3.6905.2
0‑L | 300000051516 | 4-[4-[(R)-[2-(4-Chlorophenyl)phenyl]-hydroxymethyl]piperidin-1-yl]-N-[4-[[(2R)-4-[2-hydroxyethyl(methyl)amino]-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylbenzamide | 2.16.840.1.113883.3.6905.2
0‑L | 300000054656 | (6aS)-3-[5-[[(6aS)-2-Methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-2-methoxy-8-methylidene-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-11-one | 2.16.840.1.113883.3.6905.2
0‑L | 100000143487 | STYRENE-BUTADIENE-STYRENE (SBS) AND STYRENE-BUTADIENE BLOCK CO-POLYMERS, COLOPHONIUM RESIN, ANTIOXIDANTS (2,4-BIS(1,1-DIMETHYLETHYL)PHENYL PHOSPHITE (3:1), TRIS(2,4-DI-TERT-BUTYLPHENYL)PHOSPHATE) | 2.16.840.1.113883.3.6905.2
0‑L | 100000174332 | LIQUID EXTRACT OF ICELAND MOSS, SAPONARIA OFFICINALIS ROOT, PIMPINELLA ROOT, EUCALYPTUS LEAF, FENNEL BITTER FRUIT (1:1:1:1:1) AND 1 PART OF STAR ANISE (1:3-4), EXTRACTION SOLVENT: ETHANOL 30% V/V | 2.16.840.1.113883.3.6905.2
0‑L | 100000176534 | LIQUID EXTRACT (0,65:1) FROM A MIXTURE OF: MATRICARIA FLOWER, OAK BARK, SAGE LEAF, ARNICA HERB, CALAMUS RHIZOME, PEPPERMINT HERB, THYME HERB (2:2:2:1:1:1:1), EXTRACTION SOLVENT: ETHANOL 70% (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000010760 | 2-((3-((4-((3-aminopropyl)amino)butyl)amino)propyl)amino)-N-((5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl)acetamide | 2.16.840.1.113883.3.6905.2
0‑L | 300000013167 | Dry extract from tinnevelly senna pods and alexandrian senna pods (4.5-5.5:1), 100-166.5 mg corresponding to 10 mg hydroxyanthracene glycosides, calculated as sennoside B, extraction agent: water | 2.16.840.1.113883.3.6905.2
0‑L | 300000027651 | Allogeneic bone marrow-derived haematopoietic stem and progenitor cells treated ex vivo with the protein transduction domain of the HIV-1 transactivation protein fused to MYC transcription factor | 2.16.840.1.113883.3.6905.2
0‑L | 300000027671 | Autologous bone marrow-derived haematopoietic stem and progenitor cells treated ex vivo with the protein transduction domain of the HIV-1 transactivation protein fused to MYC transcription factor | 2.16.840.1.113883.3.6905.2
0‑L | 300000052870 | [(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-Difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] propanoate | 2.16.840.1.113883.3.6905.2
0‑L | 300000054065 | Autologous peripheral blood-derived CD4 and CD8 T lymphocytes, transduced with a lentiviral vector to expressing a chimeric receptor against BCMA with co-stimulatory sequences 4-1-BB and CD3 zeta | 2.16.840.1.113883.3.6905.2
0‑L | 300000054302 | 5-[5-Chloro-2-[(3S)-3-(morpholin-4-ylmethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-N-(5-cyano-1,2-dimethylpyrrol-3-yl)-N-(4-hydroxyphenyl)-1,2-dimethylpyrrole-3-carboxamide sulfuric acid | 2.16.840.1.113883.3.6905.2
0‑L | 300000039898 | (7S,9S)-6,9,11-Trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-7-[[(2S,4R,6S,7S,9R,10S)-10-methoxy-6-methyl-5,8,11-trioxa-1-zatricyclo[7.4.0.02,7]tridecan-4-yl]oxy]-8,10-dihydro-7H-tetracene-5,12-dione | 2.16.840.1.113883.3.6905.2
0‑L | 300000041328 | 1,5-anhydro-2,3-dideoxy-4-o-methyl-3-(((1R,3S)-3-(1-methylethyl)-3-(((1S,4S)-5-(6-(trifluoromethyl)-4-pyrimidinyl)-2,5-diazabicyclo(2.2.1)hept-2-yl)carbonyl)cyclopentyl)amino)-d-erythro-pentitol | 2.16.840.1.113883.3.6905.2
0‑L | 300000017100 | 3-amino-N-{[5-[4-[bis[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]piperidine-1-carbonyl]-1,3-diethyl-benzimidazol-1-ium-2-yl]methyl}-5H-pyrrolo[2,3-b]pyrazine-2-carboxamide trifluoroacetate | 2.16.840.1.113883.3.6905.2
0‑L | 300000028552 | Turkey herpesvirus, strain HVT/NDV/ILT (cell-associated), expressing fusion protein gene of Newcastle disease virus and gD and gI glycoproteins genes of Infectious laryngotracheitis virus, Live | 2.16.840.1.113883.3.6905.2
0‑L | 300000041116 | Escherichia coli, serotype O8:K35 (fimbrial adhesin F5), strain 3014 and serotype O9:K35 (fimbrial adhesin F5), strain 3015 and serotype O101:K30 (fimbrial adhesin F5), strain 3016, Inactivated | 2.16.840.1.113883.3.6905.2
0‑L | 300000046889 | Dry extract from milk thistle fruit, (equivalent to 3.725 g – 10.818 g of milk thistle fruits) corresponding to 108 mg of silymarin, calculated as silibinin. extraction solvent: acetone 95% v/v | 2.16.840.1.113883.3.6905.2
0‑L | 300000047854 | (2S)-2-[(Z)-[1-(2-Amino-1,3-thiazol-4-yl)-2-[[(2S)-3-methyl-1-oxo-3-(sulfooxyamino)butan-2-yl]amino]-2-oxoethylidene]amino]oxy-3-[4-[N'-[(3R)-piperidin-3-yl]carbamimidoyl]phenoxy]propanoic acid | 2.16.840.1.113883.3.6905.2
0‑L | 300000041681 | H-Lys-Val-Ala-Glu-Leu-Val-His-Phe-Leu-Arg-Val-Lys-Arg-Phe-Leu-Trp-Gly-Pro-Arg-Ala-Leu-Val-Arg-Val-Lys-Arg-Val-Ile-Phe-Ser-Lys-Ala-Ser-Ser-Ser-Leu-Gln-Leu-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-OH | 2.16.840.1.113883.3.6905.2
0‑L | 300000044662 | Polypeptide consisting of a glucagon-like peptide-1 receptor agonist and an amylin receptor agonist, connected by a linker with 4 glycine residues, and connected to a C18 fatty acid side chain | 2.16.840.1.113883.3.6905.2
0‑L | 300000052865 | [2-[(6S,8S,9R,10S,11S,13S,14S,16S,17R)-6-Bromo-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate | 2.16.840.1.113883.3.6905.2
0‑L | 300000052885 | [2-[(6S,8S,9R,10S,11S,13S,14S,16S,17R)-6-Bromo-9-chloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate | 2.16.840.1.113883.3.6905.2
0‑L | 300000054371 | (2S)-N-[[4-[(4,10-Dihydro-1-methylpyrazolo[3,4-b][1,5]benzodiazepin-5(1H)-yl)carbonyl]-2-methylphenyl]methyl]-2-[(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)thioxomethyl]-1-pyrrolidinecarboxamide | 2.16.840.1.113883.3.6905.2
0‑L | 300000055878 | Dry extract of Ginkgo leaf (40-50:1), corresponding to 17.6-21.6 mg of flavone glycosides, 2.2-2.7 mg of ginkgolides A, B and C, 2.1-2.6 mg of bilobalide, Extraction solvent: ethanol 50% (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 100000177418 | (R)-2-(5-cyano-2-(6-(methoxycarbonyl)-7-methyl-3-oxo-8-(3-(trifluoromethyl)phenyl)-2,3,5,8-tetrahydro-(1,2,4)triazolo(4,3-a)pyrimidin-5-yl)phenyl)-n,n,n-trimethylethanaminium methanesulfonate | 2.16.840.1.113883.3.6905.2
0‑L | 100000177427 | Human donor haematopoietic stem and progenitor cells that have been treated ex vivo with the protein transduction domain of the HIV-1 transactivation protein fused to MYC transcription factor | 2.16.840.1.113883.3.6905.2
0‑L | 300000037858 | Liquid extract from fresh Purple coneflower root corresponding to 15-21 mg of fresh purple solhatt root, equivalent to 4 mg of dried purple solhatt root, Extraction solvent: ethanol 57.3% M/M | 2.16.840.1.113883.3.6905.2
0‑L | 300000039488 | Liquid extract from a mixture (2.5: 2.5: 1) of thyme, wild thyme, Ribwort plantain (DER 1:2.9-3.3), Extraction solvent: glycerol 85% M/M, ethanol 96% V/V and purified water (1:7.5:31.2 m/m/m) | 2.16.840.1.113883.3.6905.2
0‑L | 300000047583 | 5-[5-chloro-2-[[(3S)-3,4-dihydro-3-(4-morpholinylmethyl)-2(1H)-isoquinolinyl]carbonyl]phenyl]-N-(5-cyano-1,2-dimethyl-1H-pyrrol-3-yl)-N-(4-hydroxyphenyl)-1,2-dimethyl-1H-Pyrrole-3-carboxamide | 2.16.840.1.113883.3.6905.2
0‑L | 300000047713 | Plasmid DNA which encoding a human IgG1 antibody molecule containing a epitope derived from the TRP-2 melanoma antigen plus two helper T-cell sequences derived from the melanoma gp100 protein | 2.16.840.1.113883.3.6905.2
0‑L | 300000048052 | (S)-4-(4-(3-Chloro-4-(1-(5-fluoropyridin-2-yl)-2-hydroxyethoxy)pyrazolo[1,5-a]pyridin-6-yl)-5-methyl-1H-1,2,3-triazol-1-yl)piperidine-1-carbonitrile hemi-3,4,5-trihydroxybenzoate hemi-hydrate | 2.16.840.1.113883.3.6905.2
0‑L | 300000051643 | 7-[4-Methyl-6-(2-methylpropyl)pyridin-3-yl]-6-oxo-N-[(1R,2S)-2-(prop-2-enoylamino)cyclopentyl]-2-thia-5,7,11-triazatricyclo[6.3.1.04,12]dodeca-1(11),3,8(12),9-tetraene-3-carboxamide dihydrate | 2.16.840.1.113883.3.6905.2
0‑L | 300000051797 | Potassium sodium 4-[[2-(3-carboxylatopropanoyloxy)-1,4a-dimethyl-6-methylidene-5-[(E)-2-(5-oxo-2H-furan-4-yl)ethenyl]-3,4,5,7,8,8a-hexahydro-2H-naphthalen-1-yl]methoxy]-4-oxobutanoate hydrate | 2.16.840.1.113883.3.6905.2
0‑L | 300000034925 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Try-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Cys-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Cys-lle-lle-Gly-Leu-Met-Val-Gly-Gly-Val-Val-lle-Ala-OH hexahydrochloride | 2.16.840.1.113883.3.6905.2
0‑L | 300000046998 | Dry extract from milk thistle fruit (equivalent to 1.721 g – 5.000 g of milk thistle fruits) corresponding to 50 mg of silymarin, calculated as silibinin. Extraction solvent, acetone 95% v/v | 2.16.840.1.113883.3.6905.2
0‑L | 300000054349 | (2S,3S,4S,5R,6R)-3,4,5-Trihydroxy-6-[[(3R,5R,8R,9R,10S,13S,14S)-13-methyl-17-oxo-2,3,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxane-2-carboxylic acid | 2.16.840.1.113883.3.6905.2
0‑L | 300000056176 | Dry extract of dry raw pollen from Secale cereale, Phleum pratense and Zea mays (30:1.5:1), DER genuine 2.7-7.5:1, Extraction solvents: water, acetone, sodium laurilsulfate (27:1:0.01 w/w/w) | 2.16.840.1.113883.3.6905.2
0‑L | 100000170412 | DRY EXTRACT OF DRIED CRUDE POLLEN FROM SECALE CEREALE, PHLEUM PRATENSE AND ZEA MAYS (30:1.5:1), DER: 2.7-7.5:1, EXTRACTION SOLVENT: WATER : ACETONE : SODIUM LAURILSULFATE (96:4:0.022 M/M/M) | 2.16.840.1.113883.3.6905.2
0‑L | 300000011554 | Dry standardised extract from milk thistle fruit equivalent to 8100 g of milk thistle fruit corresponding to 174 mg of silymarin calculated as silibin, extraction solvent: acetone 95% (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000025380 | N-acetyl-L-isoleucyl-L-cysteinyl-L-valyl-N1-methyl-L-tryptophyl-L-glutaminyl-L-alpha-aspartyl-L-tryptophyl-glycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-L-threoninamide (2->12)-disulfide | 2.16.840.1.113883.3.6905.2
0‑L | 300000042459 | (8R,9S,10R,11S,13S,14S,17S)-17-(3,3-dimethylbut-1-ynyl)-17-hydroxy-13-methyl-11-[4-[methyl(propan-2-yl)amino]phenyl]-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one | 2.16.840.1.113883.3.6905.2
0‑L | 300000042468 | (3S)-3-methylsulfanyl-1-[2-[4-[4-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-N-[3-(6-propan-2-yloxypyridin-3-yl)-1H-indazol-5-yl]pyrrolidine-3-carboxamide | 2.16.840.1.113883.3.6905.2
0‑L | 300000046719 | L-Aspartyl-L-leucyl-L-arginyl-L-glutaminyl-L-methionyl-L-arginyl-L-threonyl-L-valyl-L-threonyl-L-prolyl-L-isoleucyl-L-arginyl-L-methionyl-L-glutaminyl-glycyl-glycyl-L-seryl-glycyl-L-serine | 2.16.840.1.113883.3.6905.2
0‑L | 300000054989 | Autologous CD34+ cell enriched population that contains haematopoietic stem and progenitor cells transduced ex vivo using a replication-incompetent lentiviral vector encoding the NOD2 gene | 2.16.840.1.113883.3.6905.2
0‑L | 300000018872 | Lentiviral vector, pseudotyped by Vesicular stomatitis virus envelope, New-Jersey serotype, encoding an antigen derived from Human T-lymphotropic virus 1 proteins Tax, HBZ, p12I and p30II | 2.16.840.1.113883.3.6905.2
0‑L | 300000011920 | (3R)-1-[[7-cyano-2-[3-[3-[[3-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]-1,7-naphthyridin-8-yl]amino]-2-methylphenyl]-2-methylphenyl]-1,3-benzoxazol-5-yl]methyl]pyrrolidine-3-carboxylic acid | 2.16.840.1.113883.3.6905.2
0‑L | 300000038503 | 3-[6-fluoro-10-(piperidine-1-carbonyl)-1,10-diazatricyclo[6.4.1.0^{4,13}]trideca-2,4,6,8(13)-tetraen-3-yl]-4-{imidazo[1,2-a]pyridin-3-yl}-2,5-dihydro-1H-pyrrole-2,5-dione ethanol solvate | 2.16.840.1.113883.3.6905.2
0‑L | 300000046629 | 3-(2-((1R,4aS,5R,8aS)-5,8a-dimethyl-2-methylene-5-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)decahydronaphthalen-1-yl)ethyl)furan-2(5H)-one | 2.16.840.1.113883.3.6905.2
0‑L | 100000170280 | EXTRACT (1:5,5-5,9) OF MATRICARIA FLOWER AND YARROW (2,4:1), EXTRACTION SOLVENT: ETHANOL 96 %, PURIFIED WATER, AMMONIA SOLUTION 10 %, MACROGOLGLYCEROL HYDROXYSTEARATE (52,1:50,8:1:0,25) | 2.16.840.1.113883.3.6905.2
0‑L | 300000038279 | N-{3-fluoro-4-[(3-{[(2R)-1-hydroxypropan-2-yl]amino}-1H-pyrazolo[3,4- b]pyridin-4-yl)oxy]phenyl}-3-(4-fluorophenyl)-2,4-dioxo-1-(propan-2-yl)- 1,2,3,4-tetrahydropyrimidine-5-carboxamide | 2.16.840.1.113883.3.6905.2
0‑L | 100000134946 | LIQUID EXTRACT FROM A MIXTURE OF PLANTAGO LANCEOLATA LEAF AND MALVA SYLVESTRIS FLOWER, CORRESPONDING TO 0.25 G OF LANCEOLATE LEAF AND 0.25 G OF SALIVA FLOWER, EXTRACTION SOLVENT: WATER | 2.16.840.1.113883.3.6905.2
0‑L | 300000004580 | 2,4(1H,3H)-Pyrimidinedione, 5-[6-methyl-5[(1S,2R)-2-(1-methylethyl)cyclopropyl]-3pyridazinyl]-5-{6-methyl-5-[(1S,2R)-2-(propan2-yl)cyclopropyl]pyridazin-3-yl}pyrimidine2,4(1H,3H)-dione | 2.16.840.1.113883.3.6905.2
0‑L | 300000018871 | Lentiviral vector, pseudotyped by Vesicular stomatitis virus envelope, Indiana serotype, encoding an antigen derived from Human T-lymphotropic virus 1 proteins Tax, HBZ, p12I and p30II | 2.16.840.1.113883.3.6905.2
0‑L | 300000037838 | Liquid extract from fresh Purple coneflower herb corresponding to 222-406 mg of fresh purple solhatt, equivalent to 72 mg of dried purple solhatt. Extraction solvent: ethanol 57.3% M/M | 2.16.840.1.113883.3.6905.2
0‑L | 300000054211 | 4-Benzoyl-D-phenylalanyl-D-seryl-D-tryptophyl-D-seryl-2,3,4,5,6-pentafluoro-D-phenylalanyl-3-cyclohexyl-D-alanyl-D-arginyl-D-arginyl-D-arginyl-D-glutaminyl-D-arginyl-D-arginine acetate | 2.16.840.1.113883.3.6905.2
0‑L | 300000033386 | Dry extract of Horse-chestnut equivalent to 1.08 - 1.60 g of Horse-chestnut corresponding to 50 mg of triterpene glycosides calculated as aescin, extraction solvent: ethanol 50% (v/v) | 2.16.840.1.113883.3.6905.2
0‑L | 300000041897 | L-Asparaginyl-L-tyrosinyl-L-seryl-L-glutaminyl-L-isoleucyl-L-tyrosinyl-L-prolyl-L-prolyl-L-asparaginyl-L-valyl-L-asparaginyl-L-lysyl-L-isoleucyl-L-arginyl-L-glutamyl-L-alanine acetate | 2.16.840.1.113883.3.6905.2
0‑L | 300000051796 | Potassium sodium 4-[[2-(3-carboxylatopropanoyloxy)-1,4a-dimethyl-6-methylidene-5-[(E)-2-(5-oxo-2H-furan-4-yl)ethenyl]-3,4,5,7,8,8a-hexahydro-2H-naphthalen-1-yl]methoxy]-4-oxobutanoate | 2.16.840.1.113883.3.6905.2
0‑L | 100000183760 | STANDARDIZED DRY EXTRACT OF AESCULUS HIPPOCASTANUM SEED (5-8:1) CORRESPONDING TO 40-50MG OF TRITERPENE GLYCOSIDES, EXPRESSED AS PROTOAESCIGENIN, EXTRACTION SOLVENT: ETHANOL 80% (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000041173 | Methyl (2E)-2-[(8R,9S,10R,13S,14S,17S)-2'-methoxy-2',13-dimethyl-3-oxospiro[1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-17,5'-1,3-dioxolane]-4'-ylidene]acetate | 2.16.840.1.113883.3.6905.2
0‑L | 300000049593 | 5-Fluoro-2-[(4-{7-[(1S,3S,4R)-5-methylidene-2-azabicyclo[2.2.2]octane-3-carbonyl]-2,7-diazaspiro[3.5]nonan-2-yl}pyrimidin-5-yl)oxy]-N,N-di(propan-2-yl)benzamide mono-(2R,3R)-tartrate | 2.16.840.1.113883.3.6905.2
0‑L | 100000159859 | EXTRACT (1:11) OF GENTIAN ROOT CUT, VERBENA HERB CUT, COMMON SORREL HERB CUT, ELDER FLOWER RUBBED, PRIMULA FLOWER WITH CALYX CUT: (1:3:3:3:3), EXTRACTION SOLVENT: ETHANOL, 59% (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000004100 | Adeno-associated viral vector serotype 8 containing the 5'-fragment of CEP290 gene coding sequence fused to the 5'-coding sequence of the mutated DnaE intein from Nostoc punctiforme | 2.16.840.1.113883.3.6905.2
0‑L | 300000051642 | 7-[4-Methyl-6-(2-methylpropyl)pyridin-3-yl]-6-oxo-N-[(1R,2S)-2-(prop-2-enoylamino)cyclopentyl]-2-thia-5,7,11-triazatricyclo[6.3.1.04,12]dodeca-1(11),3,8(12),9-tetraene-3-carboxamide | 2.16.840.1.113883.3.6905.2
0‑L | 100000170040 | DISTILLATE FROM BITTER FENNEL FRUIT, BITTER ORANGE PEEL, GENTIAN ROOT, PEPPERMINT LEAVES, BLESSED THISTLE HERB (1,5 : 1,5 : 1,2 : 1,0 : 1,0), DISTILLATION AGENT: ETHANOL 27 % (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000046509 | (S)-N-((3-chloro-5-(trifluoromethyl)pyridin-2-yl)methyl)-2-cyclopropyl-1-((4-fluorophenyl)sulfonyl)-2',3',5',6'-tetrahydrospiro[indoline-3,4'-thiopyran]-5-carboxamide 1',1'-dioxide | 2.16.840.1.113883.3.6905.2
0‑L | 300000051110 | (2S)-2-(3,4-Dihydroxyphenyl)-5-hydroxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-2,3-dihydrochromen-4-one | 2.16.840.1.113883.3.6905.2
0‑L | 300000052382 | (3R,6S,9R,12R,15S)-6-cyclopropyl-3,8,9,15-tetramethyl-12-(2-methylpropyl)-2-oxa-5,8,11,14-tetrazabicyclo[16.4.0]docosa-1(22),18,20-triene-7,10,13-trione sesquiphosphate monohydrate | 2.16.840.1.113883.3.6905.2
0‑L | 300000052905 | [(6S,8S,9R,10S,13S,14S,16R,17R)-6,9-Difluoro-17-(fluoromethylsulfanylcarbonyl)-10,13,16-trimethyl-3,11-dioxo-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-17-yl] propanoate | 2.16.840.1.113883.3.6905.2
0‑L | 100000130325 | DRY EXTRACT FROM MILK THISTLE (36-44:1) CORRESPONDING TO 108 MG OF SILYMARIN (HPLC) OR 140 MG SILYMARIN (DNPH), EXPRESSED AS SILIBININ, EXTRACTION SOLVENT: ETHYL ACETATE 98% (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000037401 | Standardised dry extract from Cascara sagrada (DER 4-6:1), equivalent to 15 mg of hydroxyanthracene heterosides, expressed as cascarosides a, Extraction solvent: ethanol 60% (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000044704 | DNA plasmid encoding the human IgG3 monoclonal antibody hinge and CH3, influenza A/Shanghai/2/2017 (H7N9) hemagglutinin and a single-chain variable fragment specific against HLAII | 2.16.840.1.113883.3.6905.2
0‑L | 300000049402 | Turkey herpesvirus, strain rHVT/ND/H9 (cell-associated), expressing fusion protein gene of Newcastle disease virus and hemagglutinin gene of Avian influenza virus subtype H9, Live | 2.16.840.1.113883.3.6905.2
0‑L | 300000050332 | Turkey herpesvirus, strain HVT-ND-H5 (cell-associated), expressing fusion protein gene of Newcastle disease virus and haemagglutinin gene of Avian influenza virus subtype H5, Live | 2.16.840.1.113883.3.6905.2
0‑L | 300000056621 | ({1'-[(11S)-7,8-Difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-4',6'-dioxo-1',2',4',6'-tetrahydrospiro[cyclopropane-1,3'-pyrido[1,2-b]pyridazin]-5'-yl}oxy)methyl methyl carbonate | 2.16.840.1.113883.3.6905.2
0‑L | 100000175271 | (8S,11R,13S,14S,17S)-11-(4-(Dimethylamino)phenyl)-17-hydroxy-13-methyl-17-(3-(4-methylsulfonylphenyl)prop-1-ynyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta(a)phenanthren-3-one | 2.16.840.1.113883.3.6905.2
0‑L | 100000182889 | Recombinant Vesicular Stomatitis virus (strain indiana) with a deletion of the envelope glycoprotein, replaced with the Zaire ebolavirus (strain Kikwit-1995) surface glycoprotein | 2.16.840.1.113883.3.6905.2
0‑L | 100000183263 | Allogeneic pancreatic cancer cells derived from panc 10.05 tumor cell line transfected with DNA plasmid containing the human granulocyte macrophage-colony stimulating factor gene | 2.16.840.1.113883.3.6905.2
0‑L | 300000028153 | Dry extract from Ginkgo (35-67:1), refined and quantified corresponding to 22 - 27% flavonoids, 2.6 - 3.2% bilobalide, 2.8 - 3.4% ginkgolides, Extraction solvents: acetone, water | 2.16.840.1.113883.3.6905.2
0‑L | 300000041674 | Fusion protein containing a humanised Llama single domain antibody against PSMA, a humanised Llama single domain antibody against HAS and a humanised single chain Fv against CD3e | 2.16.840.1.113883.3.6905.2
0‑L | 100000183262 | Allogeneic pancreatic cancer cells derived from panc 6.03 tumor cell line transfected with DNA plasmid containing the human granulocyte macrophage-colony stimulating factor gene | 2.16.840.1.113883.3.6905.2
0‑L | 300000032853 | Liquid extract (1:5) from Melissa leaf, Hawthorn leaf and flower, Matricaria flower, Angelica archangelica root, Caraway fruit (8:7:2:2:1), extraction solvent: ethanol 40% (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000033281 | 2-amino-4-[(4aS)-8-chloro-10-fluoro-2,3,4,4a,5,6-hexahydro-12-oxo-3-(1-oxo-2-propen-1-yl)-1H,12H-pyrazino[2,1-d][1,5]benzoxazocin-9-yl]-7-fluoro-benzo[b]thiophene-3-carbonitrile | 2.16.840.1.113883.3.6905.2
0‑L | 300000041049 | Autologous CD34+ enriched population containing haematopoietic stem and progenitor cells transduced ex vivo with a lentiviral vector encoding the human programmed death-ligand 1 | 2.16.840.1.113883.3.6905.2
0‑L | 300000054707 | Turkey herpesvirus, strain rHVT/ND/IBD (cell-associated), expressing fusion protein gene of Newcastle disease virus and VP2 protein gene of Infectious bursal disease virus, Live | 2.16.840.1.113883.3.6905.2
0‑L | 100000159896 | EXTRACT (1:38.5) FROM GENTIAN ROOT, VERBENA HERB, COMMON SORREL HERB, ELDER FLOWER, PRIMULA FLOWER WITH CALYX (1:3:3:3:3), EXTRACTING AGENTS: ETHANOL 59 % (V/V), PURIFIED WATER | 2.16.840.1.113883.3.6905.2
0‑L | 300000017101 | 3-amino-N-{[5-[4-[bis[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]piperidine-1-carbonyl]-1,3-diethyl-benzimidazol-1-ium-2-yl]methyl}-5H-pyrrolo[2,3-b]pyrazine-2-carboxamide | 2.16.840.1.113883.3.6905.2
0‑L | 300000043839 | Turkey herpesvirus, strain HVT-IBD-ND (cell-associated), expressing VP2 protein gene of Infectious bursal disease virus and fusion protein gene of Newcastle disease virus, Live | 2.16.840.1.113883.3.6905.2
0‑L | 300000050574 | 4-(5-(2-((1R,5S,7aS)-1-(3,5-Bis(trifluoromethyl)phenyl)tetrahydro-3-oxo-1H,3H-pyrrolo(1,2-C)oxazol-5-yl)-4-(trifluoromethyl)phenyl)-6-methoxy-3-pyridinyl)-3-methyl-benzoic acid | 2.16.840.1.113883.3.6905.2
0‑L | 100000174893 | DRY EXTRACT OF PINUS SYLVESTRIS POLLEN, ZEA MAYS POLLEN, SECALE CEREALE POLLEN, DACTYLIS GLOMERATA POLLEN AND ZEA MAYS PISTIL (DER 3-4:1), EXTRACTION SOLVENT: ACETONE 5% (M/M) | 2.16.840.1.113883.3.6905.2
0‑L | 100000178070 | REFINED AND STANDARDIZED DRY EXTRACT OF MILK THISTLE FRUIT (24-27: 1) CORRESPONDING TO 77.76 - 95.04 MG OF SILYMARIN, CALCULATED AS SILIBININ, EXTRACTION SOLVENT: ACETONE 95 % | 2.16.840.1.113883.3.6905.2
0‑L | 300000016580 | Mycobacterium bovis, strain Bacillus Calmette-Guérin, subtype Prague, containing listeriolysin encoding gene from Listeria monocytogenes in the place of urease C encoding gene | 2.16.840.1.113883.3.6905.2
0‑L | 300000033908 | Refined and quantified dry extract from ginkgo leaf (35-45: 1), corresponding to 15 mg of flavone glycosides and 3.5 mg of terpenlactone, Extraction solvent: acetone 60% (M/M) | 2.16.840.1.113883.3.6905.2
0‑L | 300000044639 | N-[(3R,5S,8R,9S,10S,13S,14S,17S)-17-acetyl-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-2-aminoacetamide monohydrochloride | 2.16.840.1.113883.3.6905.2
0‑L | 300000046755 | L-Asparaginyl-L-tyrosinyl-L-seryl-L-glutaminyl-L-isoleucyl-L-tyrosinyl-L-prolyl-L-prolyl-L-asparaginyl-L-valyl-L-asparaginyl-L-lysyl-L-isoleucyl-L-arginyl-L-glutamyl-L-alanine | 2.16.840.1.113883.3.6905.2
0‑L | 300000050872 | Methyl-(1-{[6-{[(1S)-1-cyclopropylethyl]amino}-2-(pyrazolo[5,1-b][1,3]thiazol-7-yl)-pyrimidin-4-yl]carbonyl}piperidin-4-yl)carbamate-mono(4-methylbenzenesulfonate) monohydrate | 2.16.840.1.113883.3.6905.2
0‑L | 300000054918 | 16,17-Dimethoxy-21-[2-(methylamino)ethyl]-5,7-dioxa-11,21-diazapentacyclo[11.8.0.02,10.04,8.014,19]henicosa-1(13),2,4(8),9,11,14,16,18-octaen-20-one-2,2,2-trifluoroacetic acid | 2.16.840.1.113883.3.6905.2
0‑L | 300000056620 | 2-Fluoro-N-{(83R,84R)-83-hydroxy-58-(propan-2-yl)-4,6-diaza-1(1)-isoquinolina-5(4,2)-pyrazolo[1,5-a][1,3,5]triazina-8(4)-piperidina-2(1,2)-benzenaoctaphan-16-yl}prop-2-enamide | 2.16.840.1.113883.3.6905.2
0‑L | 100000141671 | OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE | 2.16.840.1.113883.3.6905.2
0‑L | 300000003961 | 7-(4-((4-((5s)-5-(acetamidomethyl)-2-oxo-oxazolidin-3-yl)-2-fluoro-phenoxy)methyl)-4-phosphonooxy-1-piperidyl)-1-cyclopropyl-6-fluoro-4-oxo-quinoline-3-carboxylic acid sodium | 2.16.840.1.113883.3.6905.2
0‑L | 300000039847 | 7-acetoxy-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl 2,2-dimethyl-1,3-dioxolane-4-carboxylate | 2.16.840.1.113883.3.6905.2
0‑L | 300000043699 | Methyl(R)-4-((3S,5R,7R,8R,9S,10S,13R,14S,17R)-7-hydroxy-10,13-dimethyl-3-((4-((pyridin-3-ylmethyl)amino)butyl)amino)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate | 2.16.840.1.113883.3.6905.2
0‑L | 300000044848 | Methyl(R)-4-((3S,5R,7R,8R,9S,10S,13R,14S,17R)-7-hydroxy-10,13-dimethyl-3-((4-((pyridin-2-ylmethyl)amino)butyl)amino)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate | 2.16.840.1.113883.3.6905.2
0‑L | 100000090160 | HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA | 2.16.840.1.113883.3.6905.2
0‑L | 100000090163 | HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA | 2.16.840.1.113883.3.6905.2
0‑L | 100000090164 | HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA | 2.16.840.1.113883.3.6905.2
0‑L | 100000163404 | HUMAN PAPILLOMAVIRUS TYPE 31 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA | 2.16.840.1.113883.3.6905.2
0‑L | 100000163405 | HUMAN PAPILLOMAVIRUS TYPE 33 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA | 2.16.840.1.113883.3.6905.2
0‑L | 100000163406 | HUMAN PAPILLOMAVIRUS TYPE 45 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA | 2.16.840.1.113883.3.6905.2
0‑L | 100000163407 | HUMAN PAPILLOMAVIRUS TYPE 52 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA | 2.16.840.1.113883.3.6905.2
0‑L | 100000163408 | HUMAN PAPILLOMAVIRUS TYPE 58 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA | 2.16.840.1.113883.3.6905.2
0‑L | 100000178075 | LIQUID EXTRACT FROM A MIXTURE OF SOLANUM DULCAMARA STEM, MARRUBIUM VULGARE LEAF, ANISEED, WILD THYME AND THYME (1:2.33:3.33:2.33:19) (DER: 1: 6-7), EXTRACTION SOLVENT: WATER | 2.16.840.1.113883.3.6905.2
0‑L | 300000042419 | (1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(E)-1-(2-methylsulfanyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione | 2.16.840.1.113883.3.6905.2
0‑L | 300000054871 | Natural killer cell engager composed of a single-chain variable fragment against hepatocyte growth factor receptor, a Fab arm against NKG2D, and an Fc fragment against CD16a | 2.16.840.1.113883.3.6905.2
0‑L | 100000090165 | HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA | 2.16.840.1.113883.3.6905.2
0‑L | 100000130744 | DRY EXTRACT FROM MILK THISTLE FRUIT (DER 36-44:1) EQUIVALENT TO 75.0-80.9% SILYMARIN (DNPH) AND 58.0-62.5% (HPLC), EXPRESSED AS SILIBININ, EXTRACTION SOLVENT: ETHYL ACETATE | 2.16.840.1.113883.3.6905.2
0‑L | 100000169936 | Turkey herpesvirus, strain HVP360 (cell-associated), expressing fusion protein gene of Newcastle disease virus and VP2 protein gene of Infectious bursal disease virus, Live | 2.16.840.1.113883.3.6905.2
0‑L | 300000023939 | 4-(4-(3-((2-(tert-butylamino)ethyl)amino)-6-(5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl)pyridin-2-yl)piperidin-1-yl)-5,5-dimethyl-5,7-dihydro-6H-pyrrolo(2,3-d)pyrimidin-6-one | 2.16.840.1.113883.3.6905.2
0‑L | 300000032852 | Liquid extract (1:5) from St. John's wort, chamomile flower, peppermint leaf, rhubarb root, rose fruit, fennel fruit, coriander fruit, extraction solvent: ethanol 70% (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 100000168580 | DISTILLATE (1:7) FROM EUCALYPTUS LEAVES, PEPPERMINT LEAVES, ANISE FRUITS, BITTER FENNEL FRUITS, SAGE LEAVES (2 : 2 : 1.5 : 1.5 : 1): DISTILLATION AGENT: ETHANOL 36 % (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000004120 | Adeno-associated viral vector serotype 8 containing the 3'-coding sequence of DnaB intein from Rhodothermus marinus fused to the 3'-fragment of CEP290 gene coding sequence | 2.16.840.1.113883.3.6905.2
0‑L | 300000041398 | (2's,3R,4'S,5'R)-6-chloro-4'-(3-chloro-2-fluorophenyl)-2'-(2,2-dimethylpropyl)-N-(trans-4-hydroxycyclohexyl)-2-oxo-1,2-dihydrospiro(indole-3,3'-pyrrolidine)-5'-carboxamide | 2.16.840.1.113883.3.6905.2
0‑L | 300000041532 | N-(2-fluoro-6-methylphenyl)-5,6-dihydro-6-(4-(((5-methyl-2-(7-oxa-2-azaspiro(3.5)non-2-yl)-3-pyridinyl)carbonyl)amino)benzoyl)-4H-thieno(3,2-d)(1)benzazepine-2-carboxamide | 2.16.840.1.113883.3.6905.2
0‑L | 300000049514 | 3-[(3R)-3-[1-[5-Chloro-4-[[(1R)-1-(2,4-dichlorophenyl)ethyl]amino]-6-methylpyrimidin-2-yl]azetidin-3-yl]piperidin-1-yl]-1-methylcyclobutane-1-carboxylic acid hemi-tartrate | 2.16.840.1.113883.3.6905.2
0‑L | 300000052837 | [(7R,8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl]boronic acid | 2.16.840.1.113883.3.6905.2
0‑L | 100000143266 | EXTRACTUM SPISSUM COMPOSITUM EX: HARPAGOPHYTI RADICE (4 PARTS), ECHINACEAE PURPUREAE HERBA (3 PARTS), ULMARIAE FLORE (3 PARTS) DER 2-4:1, EXTRACTING AGENT: ETHANOL, WATER | 2.16.840.1.113883.3.6905.2
0‑L | 100000175593 | 3-[6-fluoro-10-(piperidine-1-carbonyl)-1,10-diazatricyclo[6.4.1.0^{4,13}]trideca-2,4,6,8(13)-tetraen-3-yl]-4-{imidazo[1,2-a]pyridin-3-yl}-2,5-dihydro-1H-pyrrole-2,5-dione | 2.16.840.1.113883.3.6905.2
0‑L | 300000009360 | Liquid extract from gentian root, verbena herb, common sorrel herb, elder flower, primula flower with calyx (1:3:3:3:3) (DER 1:5.9), extraction solvent: ethanol 59% (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000027009 | Liquid extract from gentian root, verbena herb, common sorrel herb, elder flower, primula flower with calyx (1:3:3:3:3) (DER 1:5.6), Extraction solvent: ethanol 59% (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000041327 | (s)-N-(4-hydroxyphenyl)-3-(6-(3-(morpholinomethyl)-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)benzo[d][1,3]dioxol-5-yl)-N-phenyl-5,6,7,8-tetrahydroindolizine-1-carboxamide | 2.16.840.1.113883.3.6905.2
0‑L | 300000041509 | (5aR,6S,6aS)-3-({2',6'-dimethyl-4'-[3-(methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl}methoxy)-5,5a,6,6a-tetrahydrocyclopropa[4,5]cyclopenta[1,2-c]pyridine-6-carboxylic acid | 2.16.840.1.113883.3.6905.2
0‑L | 300000042211 | Dry extract of horse chestnut, standardised (DER 5-7:1), adjusted to 12.5 mg of triterpene glycosides calculated as protoaescigenin, Extraction solvent: ethanol 50% (M/M) | 2.16.840.1.113883.3.6905.2
0‑L | 300000042544 | 2-[(1S)-1-[(2S,5R)-5-[4-Chloro-5-fluoro-2-(trifluoromethyl)phenyl]tetrahydro-2-furanyl]ethyl]-3,4-dihydro-7-(4-methyl-1H-imidazol-1-yl)-2H-pyrido[1,2-a]pyrazine-1,6-dione | 2.16.840.1.113883.3.6905.2
0‑L | 300000047316 | Modified Vaccinia Ankara-Bavarian Nordic encoding carcinoembryonic antigen, mucin-1 , CD80, intercellular adhesion molecule 1 and lymphocyte function-associated antigen 3 | 2.16.840.1.113883.3.6905.2
0‑L | 300000049793 | (4aS,6aR,6aS,6bR,8aR,9R,10S,12aR,14bS)-10-Hydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid | 2.16.840.1.113883.3.6905.2
0‑L | 100000180998 | Human T lymphoid progenitor cells obtained after a brief period of ex vivo culture in the presence of the fusion protein DL-4, retronectin and a combination of cytokines | 2.16.840.1.113883.3.6905.2
0‑L | 300000013149 | Sodium 3-[(4aR,6R,7R,7aS)-7-hydroxy-2-oxido-2-sulfanylidene-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-2-bromo-6-phenyl-5H-imidazo[1,2-a]purin-9-one | 2.16.840.1.113883.3.6905.2
0‑L | 300000020671 | Human Papillomavirus type 16 L1 protein adjuvanted by AS04 adsorbed on aluminium hydroxide, hydrated produced on Baculovirus Hi-5 Rix4446 cells, Trichoplusia ni. derived | 2.16.840.1.113883.3.6905.2
0‑L | 300000020672 | Human Papillomavirus type 18 L1 protein adjuvanted by AS04 adsorbed on aluminium hydroxide, hydrated produced on Baculovirus Hi-5 Rix4446 cells, Trichoplusia ni. derived | 2.16.840.1.113883.3.6905.2
0‑L | 300000040378 | L-alanyl-L-glutaminyl-L-tyrosyl-L-isoleucyl-L-lysyl-L-alanyl-L-asparaginyl-L-seryl-L-lysyl-L-phenylalanyl-L-isoleucylglycyl-L-isoleucyl-L-threonyl-L-a-glutamyl-L-leucine | 2.16.840.1.113883.3.6905.2
0‑L | 300000040989 | 1-Hydroxy-2-methylpropan-2-aminium (S)-3-(6-(difluoromethoxy)13midazol-3-yl)-3-oxo-2-3-(3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl)13midazolidine-1-yl)propanoate | 2.16.840.1.113883.3.6905.2
0‑L | 300000041483 | (1S)-1-(4-chlorophenyl)-1,4-dihydro-6-methoxy-7-(1-methylethoxy)-2-(4-(methyl((trans-4-(4-methyl-3-oxo-1-piperazinyl)cyclohexyl)methyl)amino)phenyl)-3(2H)-isoquinolinone | 2.16.840.1.113883.3.6905.2
0‑L | 300000042589 | (4S,4aS,5aR,12aS)-4-(diethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-8-[(2S)-pyrrolidin-2-yl]-7-(trifluoromethyl)-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide | 2.16.840.1.113883.3.6905.2
0‑L | 300000051923 | (3R,4R,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bR)-3-Hydroxy-4,6a,6b,8a,11,12,14b-heptamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picene-4-carboxylic acid | 2.16.840.1.113883.3.6905.2
0‑L | 100000170904 | DRY EXTRACT OF HORSE CHESTNUT, STANDARDISED (DER 5-7:1), ADJUSTED TO 30 MG OF TRITERPENE GLYCOSIDES CALCULATED AS ANHYDROUS AESCIN, EXTRACTION AGENT: ETHANOL 50 % (M/M) | 2.16.840.1.113883.3.6905.2
0‑L | 100000179994 | L-LYSYL-L-LEUCYL-L-VALYL-L-VALYL-L-VALYL-GLYCYL-L-ALANYL-L-CYSTEINYL-GLYCYL-L-VALYL-GLYCYL-L-LYSYL-L-SERYL-L-ALANYL-L-LEUCYL-L-THREONYL-L-ISOLEUCINE, HYDROCHLORIDE SALT | 2.16.840.1.113883.3.6905.2
0‑L | 300000017300 | Soft extract from purple coneflower, corresponding to 300-600 mg purple coneflower herb and to 17-29 mg purple coneflower root, extraction solvent: ethanol 57.3 % (M/M) | 2.16.840.1.113883.3.6905.2
0‑L | 300000020691 | Mixture of allergen extracts from Alnus spp., Fraxinus spp., Fagus spp., Betula spp., Ulmus spp., Corylus spp., Quercus spp., Planatus spp., Populus spp. and Salix spp. | 2.16.840.1.113883.3.6905.2
0‑L | 300000040250 | Clostridium botulinum A, strain PM-12759 Hall-A, botulin A conjugated to protein NTNH, hemagglutinin HA17, hemagglutinin HA34, hemagglutinin HA23 and hemagglutinin HA48 | 2.16.840.1.113883.3.6905.2
0‑L | 100000173488 | EXTRACT (0,218:1) OF BITTER ORANGE PEEL, CONDURANGO, CLOVE, GINGER, CINNAMON AND ANGELICA ARCHANGELICA ROOT (625:10:9:5:2,5:1), EXTRACTION SOLVENT: ETHANOL 70% (V / V) | 2.16.840.1.113883.3.6905.2
0‑L | 100000174320 | DRY EXTRACT (4.2-5.6:1) OF CASCARA 57-108 MG, CORRESPONDING TO 20 MG OF HYDROXYANTHRACENE DERIVATIVES, CALCULATED AS CASCAROSIDE A, EXTRACTION SOLVENT: ETHANOL 52% M/M | 2.16.840.1.113883.3.6905.2
0‑L | 100000179995 | L-LYSYL-L-LEUCYL-L-VALYL-L-VALYL-L-VALYL-GLYCYL-L-ALANYL-L-ASPARTYL-GLYCYL-L-VALYL-GLYCYL-L-LYSYL-L-SERYL-L-ALANYL-L-LEUCYL-L-THREONYL-L-ISOLEUCINE, HYDROCHLORIDE SALT | 2.16.840.1.113883.3.6905.2
0‑L | 100000179999 | L-LYSYL-L-LEUCYL-L-VALYL-L-VALYL-L-VALYL-GLYCYL-L-ALANYL-GLYCYL-L-ASPARTYL-L-VALYL-GLYCYL-L-LYSYL-L-SERYL-L-ALANYL-L-LEUCYL-L-THREONYL-L-ISOLEUCINE, HYDROCHLORIDE SALT | 2.16.840.1.113883.3.6905.2
0‑L | 100000183784 | Adeno-associated viral vector serotype 8 containing the 5'-half region of CEP290 gene coding sequence fused to the 5'-coding sequence of Nostoc punctiforme DnaE intein | 2.16.840.1.113883.3.6905.2
0‑L | 300000037206 | Milk thistle fruit dry extract, refined and standardised (35-50:1), corresponding to 22.5 mg silymarin, calculated as silibinin, Extraction solvent: methanol 98% (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000039345 | Milk thistle fruit dry extract, refined and standardised (22-27:1), corresponding to 70 mg of silymarin, calculated as silibinin, Extraction solvent: acetone 95% (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000040809 | 7-(4-((4-((5S)-5-(acetamidomethyl)-2-oxo-oxazolidin-3-yl)-2-fluoro-phenoxy)methyl)-4-phosphonooxy-1-piperidyl)-1-cyclopropyl-6-fluoro-4-oxo-quinoline-3-carboxylic acid | 2.16.840.1.113883.3.6905.2
0‑L | 300000042365 | 5-[(4S)-4-hydroxy-4-methyl-1,2-oxazolidine-2-carbonyl]-3-methyl-6-[[5-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]methyl]-1-propan-2-ylthieno[2,3-d]pyrimidine-2,4-dione | 2.16.840.1.113883.3.6905.2
0‑L | 300000046173 | Ethyl(2E,4S)-4-({(2S)-2-[3-{[(5-methyl-1,2-oxazol-3-yl)carbonyl]amino}-2-oxopyridin-1(2H)-yl]pent-4-ynoyl}amino)-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoate monohydrate | 2.16.840.1.113883.3.6905.2
0‑L | 300000049196 | Refined and standardized dry extract of Milk Thistle fruit (24-27:1), corresponding to 4.06 mg of silymarin expressed as silibinin. Extraction solvent: acetone 95% v/v | 2.16.840.1.113883.3.6905.2
0‑L | 300000054139 | 4-[[[4-[5-Chloro-2-[[trans-4-[[(1R)-2-methoxy-1-methyl-ethyl]amino]cyclohexyl]amino]-4-pyridinyl]-2-thiazolyl]amino]methyl]tetrahydro-2H-pyran-4-carbonitrile dimaleate | 2.16.840.1.113883.3.6905.2
0‑L | 300000057673 | (14S,18S)-1-(6-hydrazineylpyridin-3-yl)-1,8,16-trioxo-2,9,15,17-tetraazaicosane-14,18,20-tricarboxylic acid conjugated to bombesin and radiolabeled with technetium-99m | 2.16.840.1.113883.3.6905.2
0‑L | 300000057752 | [(3S)-3-Amino-3-carboxypropyl]-[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-methylsulfanium butane-1,4-disulfonate butane-1,4-disulfonic acid | 2.16.840.1.113883.3.6905.2
0‑L | 100000139506 | EXTRACTUM LIQUIDUM (1:3) EX: CHAMOMILLAE ANTHODIO, HYPERICI HERBA, GLYCYRRHIZAE RADICE, SALVIAE FOLIO, MENTHAE PIPERITAE FOLIO (2,5 P: 2,5 P.: 2,0 P.: 2,0 P.: 1,0 P.) | 2.16.840.1.113883.3.6905.2
0‑L | 100000174319 | LIQUID EXTRACT (1:1.0-1.2) OF CASCARA 500 MG, CORRESPONDING TO 20 MG OF HYDROXYANTHRACENE GLYCOSIDES, CALCULATED AS CASCAROSIDE A, EXTRACTION SOLVENT: ETHANOL 30% M/M | 2.16.840.1.113883.3.6905.2
0‑L | 100000179996 | L-LYSYL-L-LEUCYL-L-VALYL-L-VALYL-L-VALYL-GLYCYL-L-ALANYL-L-ARGINYL-GLYCYL-L-VALYL-GLYCYL-L-LYSYL-L-SERYL-L-ALANYL-L-LEUCYL-L-THREONYL-L-ISOLEUCINE, HYDROCHLORIDE SALT | 2.16.840.1.113883.3.6905.2
0‑L | 100000183279 | Adeno-associated viral vector serotype 8 containing the 5'-half region of ABCA4 gene coding sequence fused to the 5'-coding sequence of Nostoc punctiforme DnaE intein | 2.16.840.1.113883.3.6905.2
0‑L | 300000016600 | Mixture of allergen extracts of Phleum pratense, Dactylis glomerata, Poa pratensis, Holcus lanatus, Festuca elatior and Lolium perenne polymerized with glutaraldehyde | 2.16.840.1.113883.3.6905.2
0‑L | 300000032682 | Autologous CD34+ haematopoietic stem and progenitor cells genetically modified with the lentiviral vector encoding for the human palmitoyl-protein thioesterase 1 gene | 2.16.840.1.113883.3.6905.2
0‑L | 300000033927 | Autologous CD34+ cell enriched population containing haematopoietic stem and progenitor cells transduced ex vivo with a lentiviral vector encoding the human ADA2 gene | 2.16.840.1.113883.3.6905.2
0‑L | 300000039365 | (R)-1-(tert-butyl)-N-(8-(2-((1-methyl-1H-pyrazol-4-yl)amino)pyrimidin-4-yl)-2-(oxetan-3-yl)-2,3,4,5-tetrahydro-1H-benzo[c]azepin-5-yl)-1H-1,2,3-triazole-4-carboxamide | 2.16.840.1.113883.3.6905.2
0‑L | 300000052894 | (8R,9S,13S,14S,17S)-13-Methyl-7-[9-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonylsulfinyl]nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol | 2.16.840.1.113883.3.6905.2
0‑L | 100000172697 | MILK THISTLE DRY EXTRACT, REFINED AND STANDARDISED 123,0 - 208,3 MG CORRESPONDING TO 83,3 MG OF SILYMARIN, CALCULATED AS SILIBININ, EXTRACTION SOLVENT: ETHYL ACETATE | 2.16.840.1.113883.3.6905.2
0‑L | 100000179993 | L-LYSYL-L-LEUCYL-L-VALYL-L-VALYL-L-VALYL-GLYCYL-L-ALANYL-L-ALANYL-GLYCYL-L-VALYL-GLYCYL-L-LYSYL-L-SERYL-L-ALANYL-L-LEUCYL-L-THREONYL-L-ISOLEUCINE, HYDROCHLORIDE SALT | 2.16.840.1.113883.3.6905.2
0‑L | 100000184187 | Autologous skin equivalent graft composed of keratinocytes and fibroblasts genetically corrected by CRISPR/Cas9-mediated excision of mutation-carrying COL7A1 exon 80 | 2.16.840.1.113883.3.6905.2
0‑L | 300000026364 | Standardised dry extract of frangula bark (DER 5-7: 1) corresponding to 15 mg of glucofrangulins expressed as glucofrangulin A, extraction solvent: ethanol 60% (M/M) | 2.16.840.1.113883.3.6905.2
0‑L | 300000037257 | Dry extract from Hippophae rhamnoides, refined and standardised (DER 35-50:1), corresponding to 110 mg silymarin, calculated as silibin, Extraction solvent: methanol | 2.16.840.1.113883.3.6905.2
0‑L | 300000041564 | Refined and quantified dry extract of ginkgo leaf (35-67:1), quantified to 24% of ginkgo glycosides, 6% ginkgolides-bilobalide, Extraction solvent: acetone 60% (M/M) | 2.16.840.1.113883.3.6905.2
0‑L | 300000046508 | Refined and quantified dry extract from Ginkgo leaf, corresponding to 9.6 mg of glycosides and 2.4 mg ginkgolides and bilobalide, Extraction solvent: acetone 60% M/M | 2.16.840.1.113883.3.6905.2
0‑L | 300000056642 | (10R)-7-Amino-12-fluoro-2-(2H3)methyl-10,16-dimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile | 2.16.840.1.113883.3.6905.2
0‑L | 300000057674 | (14S,18S)-1-(6-hydrazineylpyridin-3-yl)-1,8,16-trioxo-2,9,15,17-tetraazaicosane-14,18,20-tricarboxylic acid conjugated to bombesin and radiolabeled with lutetium-177 | 2.16.840.1.113883.3.6905.2
0‑L | 100000179997 | L-LYSYL-L-LEUCYL-L-VALYL-L-VALYL-L-VALYL-GLYCYL-L-ALANYL-L-SERYL-GLYCYL-L-VALYL-GLYCYL-L-LYSYL-L-SERYL-L-ALANYL-L-LEUCYL-L-THREONYL-L-ISOLEUCINE, HYDROCHLORIDE SALT | 2.16.840.1.113883.3.6905.2
0‑L | 100000179998 | L-LYSYL-L-LEUCYL-L-VALYL-L-VALYL-L-VALYL-GLYCYL-L-ALANYL-L-VALYL-GLYCYL-L-VALYL-GLYCYL-L-LYSYL-L-SERYL-L-ALANYL-L-LEUCYL-L-THREONYL-L-ISOLEUCINE, HYDROCHLORIDE SALT | 2.16.840.1.113883.3.6905.2
0‑L | 300000011402 | Dry extract from tribulus terrestris herba (35-45:1), corresponding to 125 mg furostanol saponins calculated as protodioscin, extraction solvent: methanol 80% (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000044020 | [(2S,3S,4E,6S,7R,10R)-7,10-Dihydroxy-3,7-dimethyl-12-oxo-2-[(2E,4E,6R)-6-pyridin-2-ylhepta-2,4-dien-2-yl]-1-oxacyclododec-4-en-6-yl]4-methylpiperazine-1-carboxylate | 2.16.840.1.113883.3.6905.2
0‑L | 300000052893 | (1S,3S,5S,6S,10R,12S,13S,15S,21S)-15-Fluoro-6-(2-hydroxyacetyl)-5,8,8,21-tetramethyl-2,7,9-trioxahexacyclo[11.8.0.01,3.05,12.06,10.016,21]henicosa-16,19-dien-18-one | 2.16.840.1.113883.3.6905.2
0‑L | 100000184144 | MILK THISTLE FRUIT DRY EXTRACT, REFINED AND STANDARDISED (22-27:1) CORRESPONDING TO 200 MG OF SYLIMARIN, CALCULATED AS SYLIBIN, EXTRACTION SOLVENT: ACETONE 95% V/V | 2.16.840.1.113883.3.6905.2
0‑L | 300000013240 | Milk thistle fruit dry extract, refined and standardised (22-27:1), corresponding to 140 mg silymarin, calculated as silibinin, extraction solvent: acetone 95% V/V | 2.16.840.1.113883.3.6905.2
0‑L | 300000018300 | Pneumococcal polysaccharide serotype 23F conjugated to protein D (derived from non-typeable Haemophilus influenzae) carrier protein adsorbed on aluminium phosphate | 2.16.840.1.113883.3.6905.2
0‑L | 300000032854 | Liquid extract (1:2) from Valerian root, Melissa herb, Angelica archangelica root, Hop strobile, Lavender flower (5:5:4:3:3), extraction solvent: ethanol 60% (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000041471 | 4-((9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino)-2-fluoro-5-methoxy-N-(1-methylpiperidin-4-yl)benzamide | 2.16.840.1.113883.3.6905.2
0‑L | 300000050858 | Methyl-(1-{[6-{[(1S)-1-cyclopropylethyl]amino}-2-(pyrazolo[5,1-b][1,3]thiazol-7-yl)-pyrimidin-4-yl]carbonyl}piperidin-4-yl)carbamate-mono(4-methylbenzenesulfonate) | 2.16.840.1.113883.3.6905.2
0‑L | 300000051415 | Autologous T-cells expressing an antibody coupled T-cell receptor composed of CD16 extracellular domain, CD3zeta-signaling domain and a 4-1BB co-stimulatory domain | 2.16.840.1.113883.3.6905.2
0‑L | 300000051582 | Extract of Phoradendron leucarpum herb (1:50), Extraction solvent: sodium monohydrogen phosphate dihydrate, ascorbic acid and water for injection (2.03:0.34:97.63) | 2.16.840.1.113883.3.6905.2
0‑L | 300000052817 | Cis-4-(2-fluoro-4-methoxy-5-{[(1S,2R,3S,4R)-3-{[(1-methylcyclobutyl)methyl]carbamoyl}bicyclo[2.2.1]heptan2-yl]carbamoyl}phenoxy)-1-methylcyclohexanecarboxylic acid | 2.16.840.1.113883.3.6905.2
0‑L | 300000055990 | Dry extract of Rhubarb (DER: 3-5 :1), corresponding to 12.5 mg of hydroxyanthracene glycosides, expressed as rhein-8-glucoside, Extraction solvent: ethanol 70% V/V | 2.16.840.1.113883.3.6905.2
0‑L | 100000175091 | 2,2-dimethylpropyl (2S)-2-[[[(2R,3R,4R,5R)-5-(2-amino-6-methoxypurin-9-yl)-3,4-dihydroxy-4-methyloxolan-2-yl]methoxy-naphthalen-1-yloxyphosphoryl]amino]propanoate | 2.16.840.1.113883.3.6905.2
0‑L | 300000013150 | 3-[(4aR,6R,7R,7aS)-7-hydroxy-2-oxido-2-sulfanylidene-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-2-bromo-6-phenyl-5H-imidazo[1,2-a]purin-9-one | 2.16.840.1.113883.3.6905.2
0‑L | 300000018294 | Pneumococcal polysaccharide serotype 6B conjugated to protein D (derived from non-typeable Haemophilus influenzae) carrier protein adsorbed on aluminium phosphate | 2.16.840.1.113883.3.6905.2
0‑L | 300000018295 | Pneumococcal polysaccharide serotype 7F conjugated to protein D (derived from non-typeable Haemophilus influenzae) carrier protein adsorbed on aluminium phosphate | 2.16.840.1.113883.3.6905.2
0‑L | 300000018296 | Pneumococcal polysaccharide serotype 9V conjugated to protein D (derived from non-typeable Haemophilus influenzae) carrier protein adsorbed on aluminium phosphate | 2.16.840.1.113883.3.6905.2
0‑L | 300000018297 | Pneumococcal polysaccharide serotype 14 conjugated to protein D (derived from non-typeable Haemophilus influenzae) carrier protein adsorbed on aluminium phosphate | 2.16.840.1.113883.3.6905.2
0‑L | 300000034979 | Autologous haematopoietic stem and progenitor cell population containing CD34+ cells transduced with a lentiviral vector encoding the TCIRG1 cDNA ex vivo expanded | 2.16.840.1.113883.3.6905.2
0‑L | 300000038478 | Autologous CD34+ cells edited with CRISPR/Cas9 and transduced with an adeno-associated virus vector serotype 6 containing the codon-optimized version of PKLR gene | 2.16.840.1.113883.3.6905.2
0‑L | 300000043943 | (2R,4E)-7-chloro-4-(2-oxo-1-phenyl-pyrrolidin-3-ylidene)-1,2,3,4-tetrahydroquinoline-2-carboxylic acid, (2R,3R,4R,5S)-6-methylamino-hexane-1,2,3,4,5-pentanol salt | 2.16.840.1.113883.3.6905.2
0‑L | 300000052886 | [2-[(1S,2S,8S,10S,11S,14R,15S,17S)-14-Acetyloxy-8-fluoro-2,15-dimethyl-5-oxo-18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadeca-3,6-dien-14-yl]-2-oxoethyl] acetate | 2.16.840.1.113883.3.6905.2
0‑L | 300000053091 | (7S,8R,9S,13S,14S,17S)-3,17-dihydroxy-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-6-one | 2.16.840.1.113883.3.6905.2
0‑L | 300000056634 | 6-(3-Hydroxy-3-methylazetidin-1-yl)-4-(6-{6-[(6-methoxypyridin-3-yl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl}pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile | 2.16.840.1.113883.3.6905.2
0‑L | 300000057747 | Butan-2-yl [1-methyl-4-[[4-[[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]carbamoyl]phenyl]methyl]piperazin-1-ium-1-yl]methyl carbonate methanesulfonate | 2.16.840.1.113883.3.6905.2
0‑L | 100000143028 | AQUEOUS EXTRACT FROM 0,600 G THYME, 0,131 G LIME BLOSSOM, 0,116 G PRIMROSE FLOWER, 0,095 G ANISEED, 0,095 G BITTER FENNEL, 0,085 G SUNDEW HERB, 0,042 G KNOTGRASS | 2.16.840.1.113883.3.6905.2
0‑L | 300000003968 | L-valyl-L-cysteinyl-L-histidyl-L-seryl-L-lysyl-L-threonyl-L-arginyl-L-seryl-L-asparaginyl-L-prolyl-L-glutamyl-L-asparaginyl-L-asparaginyl-L-valylglycyl-L-leucine | 2.16.840.1.113883.3.6905.2
0‑L | 300000011380 | Dry extract from horse chestnut seed (4.5-5.5:1) corresponding to 50 mg triterpene glycosides calculated as anhydrous aescin, extraction solvent: ethanol 50% V/V | 2.16.840.1.113883.3.6905.2
0‑L | 300000018291 | Pneumococcal polysaccharide serotype 1 conjugated to protein D (derived from non-typeable Haemophilus influenzae) carrier protein adsorbed on aluminium phosphate | 2.16.840.1.113883.3.6905.2
0‑L | 300000018292 | Pneumococcal polysaccharide serotype 4 conjugated to protein D (derived from non-typeable Haemophilus influenzae) carrier protein adsorbed on aluminium phosphate | 2.16.840.1.113883.3.6905.2
0‑L | 300000018293 | Pneumococcal polysaccharide serotype 5 conjugated to protein D (derived from non-typeable Haemophilus influenzae) carrier protein adsorbed on aluminium phosphate | 2.16.840.1.113883.3.6905.2
0‑L | 300000044122 | (2S,3R,4S,5S,6R)-2-[4-[(3R,3aR,6S,6aR)-3-(3,4-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]-2-methoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol | 2.16.840.1.113883.3.6905.2
0‑L | 100000131733 | HIPPOCASTANI SEMEN EXTRACTUM SICCUM (5,3 - 7,7 : 1), ADJUSTED TO 40 MG OF TRITERPENE GLYCOSIDES, CALCULATED AS ANHYDROUS ESCINE, EXTRACTION MEDIUM: METHANOL 80% | 2.16.840.1.113883.3.6905.2
0‑L | 100000177747 | 1-(4-(2-(4-(1-(3-(trifluoromethyl)-7,8-dihydro-(1,2,4)triazolo(4,3-b)pyridazin-6-yl)piperidin-4-yl)phenoxy)ethyl)piperazin-1-yl)ethanone (Z)-but-2-enedioic acid | 2.16.840.1.113883.3.6905.2
0‑L | 100000182954 | Adeno-associated viral vector serotype 8 containing a functional copy of the codon-optimised F8 cDNA encoding the B-domain deleted human coagulation factor VIII | 2.16.840.1.113883.3.6905.2
0‑L | 300000022311 | (S,E)-N-(1-((5-(2-((4-cyanophenyl)amino)-4-(propylamino)pyrimidin-5-yl)pent-4-yn-1-yl)amino)-1-oxopropan-2-yl)-4-(dimethylamino)-N-methylbut-2-enamide succinate | 2.16.840.1.113883.3.6905.2
0‑L | 300000024532 | [14C]-1-{3,5-dimethyl-4-[2-({4-oxo-2-[4-(trifluoromethoxy)phenyl]-1,3,8-triazaspiro[4.5]dec-1-en-8-yl}sulfonyl)ethyl]phenyl}-5,5-dimethylimidazolidine-2,4-dione | 2.16.840.1.113883.3.6905.2
0‑L | 300000040529 | Mixture of heat-inactivated, non-lysate, bacterial concentrates of Escherichia coli, Klebsiella pneumoniae, Proteus vulgaris and Enterococcus faecalis (1:1:1:1) | 2.16.840.1.113883.3.6905.2
0‑L | 300000041473 | 3-[(3R,3aR,5aS,6R,7z,9aS,9bS)-7-hydroxyimino-3a,6-dimethyl-3-[(2R)-6-methylheptan-2-yl]-1,2,3,4,5,5a,8,9,9a,9b-decahydrocyclopenta[a]naphthalen-6-yl]propan-1-ol | 2.16.840.1.113883.3.6905.2
0‑L | 300000043981 | S-(4-(3-fluoro-3-methylbutyryloxy)but-2-ynyl)-6a,9a-difluoro-17a-(furan-2-yl)carbonyloxy-11-beta-hydroxy-16a-methyl-3-oxoandrosta-1,4-diene-17-beta-carbothioate | 2.16.840.1.113883.3.6905.2
0‑L | 100000181823 | DRY EXTRACT FROM FRESH HORSE CHESTNUT SEEDS CORRESPONDING TO 50 MG TRITERPENE GLYCOSIDES, CALCULATED AS ANHYDROUS B-AESCIN, EXTRACTION SOLVENT: ETHANOL 60% M/M | 2.16.840.1.113883.3.6905.2
0‑L | 300000011300 | Dry extract from bearberry leaf corresponding to 62.3-77.7 mg of hydroquinone derivative calculated as anhydrous arbutin, extraction solvent: ethanol 60% (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000019132 | N-((1R,2S,5R)-5-((1,1-dimethylethyl)amino)-2-((3S)-3-((7-(1,1-dimethylethyl)pyrazolo(1,5-a)-1,3,5-triazin-4-yl)amino)-2-oxo-1-pyrrolidinyl)cyclohexyl)acetamide | 2.16.840.1.113883.3.6905.2
0‑L | 300000027031 | N-(2,6-Diethylphenyl)-8-({4-[4-(dimethylamino)piperidin-1-yl]-2-methoxyphenyl}amino)-1-methyl-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide phosphate | 2.16.840.1.113883.3.6905.2
0‑L | 300000038472 | Autologous CD34+ haematopoietic stem and progenitor cells genetically modified with a lentiviral vector encoding for the N-acetylgalactosamine 6-sulfatase cDNA | 2.16.840.1.113883.3.6905.2
0‑L | 300000041446 | (6S,9S,9aS)-N-benzyl-6-[(4-hydroxyphenyl)methyl]-2,9-dimethyl-4,7-dioxo-8-(quinolin-8-ylmethyl)-3,6,9,9a-tetrahydropyrazino[2,1-c][1,2,4]triazine-1-carboxamide | 2.16.840.1.113883.3.6905.2
0‑L | 300000043983 | (3S)-3-[2-(6-Amino-2-fluoropyridin-3-yl)-4-fluoro-1H-imidazol-5-yl]-7-[5-chloro-2-(1Htetrazol-1-yl)phenyl]-2,3-dihydroindolizin-5(1H)-one 3-hydroxybenzoic acid | 2.16.840.1.113883.3.6905.2
0‑L | 300000047774 | Leu-Asn-Ser-Lys-Ile-Ala-Phe-Lys-Ile-Val-Ser-Gln-Glu-Pro-Ala conjugated to an iron oxide core coated with low-molecular-weight poly(maleic acid-alt1-octadecene) | 2.16.840.1.113883.3.6905.2
0‑L | 300000047775 | Thr-Pro-Met-Phe-Leu-Leu-Ser-Arg-Asn-Thr-Gly-Glu-Val-Arg-Thr conjugated to an iron oxide core coated with low-molecular-weight poly(maleic acid-alt1-octadecene) | 2.16.840.1.113883.3.6905.2
0‑L | 300000047798 | Arg-Glu-Gly-Ile-Ala-Phe-Arg-Pro-Ala-Ser-Lys-Thr-Phe-Thr-Val conjugated to an iron oxide core coated with low-molecular-weight poly(maleic acid-alt1-octadecene) | 2.16.840.1.113883.3.6905.2
0‑L | 300000047799 | Asn-Ile-Lys-Val-Lys-Asp-Val-Asn-Asp-Asn-Phe-Pro-Met-Phe-Arg conjugated to an iron oxide core coated with low-molecular-weight poly(maleic acid-alt1-octadecene) | 2.16.840.1.113883.3.6905.2
0‑L | 300000052153 | Adeno-associated viral vector serotype 9 containing the human MECP2 gene, an intron encoding a miRNA generating sequence, and complementary miRNA binding sites | 2.16.840.1.113883.3.6905.2
0‑L | 300000056041 | Milk thistle dry extract, refined and standardised (22-27:1) of nominal content of silymarin, expressed as silibinin 58%, Extraction solvent: 95% acetone (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000027279 | Dry extract from senna pods and (DER 4.5-5.5:1), corresponding to 19.5 mg of hydroxyanthracene glycosides, expressed as sennoside B, Extraction solvent: water | 2.16.840.1.113883.3.6905.2
0‑L | 300000031916 | 3-(4-{(5S)-4-Amino-2-[6-chloro-1-(3,3,4,4,4-pentafluorobutyl)-1H-indazol-3-yl]-5-methyl-6-oxo6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-5-yl}phenyl)propanoic acid | 2.16.840.1.113883.3.6905.2
0‑L | 300000043587 | Dry extract from milk thistle fruit, refined and standardised (DER 30:1), corresponding to 35 mg silymarin, calculated as silibin, Extraction solvent: acetone | 2.16.840.1.113883.3.6905.2
0‑L | 300000052854 | [(1S,8R,9S,10S,13S,14S,17R)-17-Acetyl-6-chloro-1-(chloromethyl)-10,13-dimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate | 2.16.840.1.113883.3.6905.2
0‑L | 300000054411 | (3S,8S,9S,10R,13R,14S,17R)-17-[(E,2R,5R)-5,6-Dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | 2.16.840.1.113883.3.6905.2
0‑L | 100000128887 | HEPATITIS A VIRUS (STRAIN CR 326F) (INACTIVATED) PRODUCED ON HUMAN DIPLOID (MRC–5) FIBROBLAST CELLS ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE | 2.16.840.1.113883.3.6905.2
0‑L | 100000143256 | EXTRACTUM SPISSUM COMPOSITUM (4-7 : 1) EX: BETULAE FOLIO 4,40 CZ., PETROSELINI RADICE 2,66 CZ., PHASEOLI PERICARPIO 1,00 CZ., EKSTRAHENT: METANOL 90 % [V/V]) | 2.16.840.1.113883.3.6905.2
0‑L | 100000177372 | 3-(1,2,4-triazolo[4,3-a]pyridine-3-ylethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-trifluoromethylphenyl)benzamide mono methanesulfonic acid salt | 2.16.840.1.113883.3.6905.2
0‑L | 300000004140 | Combination of three adeno-associated viral vectors of serotype 8 containing the 5'-, the body- and the 3'- coding sequences of human CEP290 fused to inteins | 2.16.840.1.113883.3.6905.2
0‑L | 300000020954 | 2-[1-(3-{6-[(1E)-(hydroxyimino)methyl]-5-methyl-4-oxo-7-propyl-3H,4H-pyrrolo[2,1-f][1,2,4]triazin-2-yl}-4-propoxybenzenesulfonyl)piperidin-4-yl]ethyl nitrate | 2.16.840.1.113883.3.6905.2
0‑L | 300000025463 | Dry extract from Cucurbita pepo seeds deffatted (DER 5-10:1), extraction solvents: sodium hydrogen carbonate, sodium chloride and purified water (3-6,1-90,9) | 2.16.840.1.113883.3.6905.2
0‑L | 300000027791 | Dry extract from cranberry fruit juice, corresponding to 36 mg of proanthocyanidins, calculated as proanthocyanidin A2, Extraction solvent: ethanol 70% (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000033589 | (2E)-N,N-Dimethyl-4-{[2-({5-[(1Z)-4,4,4-trifluoro-1-(3-fluoro-1H-indazol-5-yl)-2-phenylbut-1-en-1-yl]pyridin-2-yl}oxy)ethyl]amino}but-2-enamide hydrochloride | 2.16.840.1.113883.3.6905.2
0‑L | 300000041501 | 2-((R)-8-(3,5-difluorophenyl)-10-oxo-6,9-diazaspiro[4.5]decan-9-yl)-N-((R)-2'-oxo-1,1',2',3-tetrahydrospiro[indene-2,3'-pyrrolo[2,3-b]pyridin]-5-yl)acetamide | 2.16.840.1.113883.3.6905.2
0‑L | 300000043020 | Dry extract of crude pollen of Secale cereale, Phleum pratense and Zea mays (30:1.5:1), Extraction solvent water:acetone:sodium laurilsulfate (27:1:0.01 w/w) | 2.16.840.1.113883.3.6905.2
0‑L | 300000044691 | N-[(3R,5S,8R,9S,10S,13S,14S,17S)-17-acetyl-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-2-aminoacetamide | 2.16.840.1.113883.3.6905.2
0‑L | 300000046674 | Liquid extract from fresh purple coneflower root (DER 1:11), corresponding to 17-29 mg of fresh purple coneflower root, extraction solvent: ethanol 57.3% M/M | 2.16.840.1.113883.3.6905.2
0‑L | 300000051751 | Salmonella typhi, strain Ty21a, Live encoding a fusion protein composed of prostate specific antigen, cholera toxin B subunit and a secretion signal sequence | 2.16.840.1.113883.3.6905.2
0‑L | 300000054366 | Allergenic extract of grass pollen mixture: Dactylis glomerata, Festuca pratensis, Lolium perenne, Phleum pratense and Poa pratensis (1:1:1:1:1), polymerised | 2.16.840.1.113883.3.6905.2
0‑L | 100000143027 | DISTILLATE FROM 0,600 G THYME, 0,131 G LIME BLOSSOM, 0,116 G PRIMROSE FLOWER, 0,095 G ANISEED, 0,095 G BITTER FENNEL, 0,085 G SUNDEW HERB, 0,042 G KNOTGRASS | 2.16.840.1.113883.3.6905.2
0‑L | 100000174280 | DRY EXTRACT OF HORSE CHESTNUT SEEDS (5-8:1) ADJUSTED TO 50 MG OF TRITERPENE GLYCOSIDES CALCULATED AS ANHYDROUS AESCIN, EXTRACTION AGENT: METHANOL 80 % (V/V) | 2.16.840.1.113883.3.6905.2
0‑L | 300000015541 | Allogeneic CD4+ and CD8+ T lymphocytes ex vivo incubated with synthetic peptides of the viral antigens of Cytomegalovirus, Adenovirus and Epstein-Barr virus | 2.16.840.1.113883.3.6905.2
0‑L | 300000032960 | 1-((3S,8S,9S,10R,13S,14S,17S)3-benzyloxy-10,13,17-trimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1Hcyclopenta[a]phenanthrene-17-yl)ethan-1-one | 2.16.840.1.113883.3.6905.2
0‑L | 300000037318 | Milk thistle fruit dry extract, refined and standardised (35-50:1), corresponding to 110 mg silymarin, calculated as silibinin, Extraction solvent: methanol | 2.16.840.1.113883.3.6905.2
0‑L | 300000042171 | Gly-Gln-Ala-Glu-Pro-Asp-Arg-Ala-His-Tyr-Asn-Ile-Val-Thr-Phe-Cys-Cys-Lys-Cys-Asp-Ser-Thr-Leu-Arg-Leu-Cys-Val-Gln-Ser-Thr-His-Val-Asp-Ile-Arg trifluoroacetate | 2.16.840.1.113883.3.6905.2
0‑L | 300000044062 | Leu-Tyr-Cys-Tyr-Glu-Gln-Leu-Asn-Asp-Ser-Ser-Glu-Glu-Glu-Asp-Glu-Ile-Asp-Gly-Pro-Ala-Gly-Gln-Ala-Glu-Pro-Asp-Arg-Ala-His-Tyr-Asn-Ile-Val-Thr trifluoroacetate | 2.16.840.1.113883.3.6905.2
0‑L | 300000044063 | Met-His-Gly-Asp-Thr-Pro-Thr-Leu-His-Glu-Tyr-Met-Leu-Asp-Leu-Gln-Pro-Glu-Thr-Thr-Asp-Leu-Tyr-Cys-Tyr-Glu-Gln-Leu-Asn-Asp-Ser-Ser-Glu-Glu-Glu trifluoroacetate | 2.16.840.1.113883.3.6905.2
0‑L | 300000044064 | Thr-Leu-Arg-Leu-Cys-Val-Gln-Ser-Thr-His-Val-Asp-Ile-Arg-Thr-Leu-Glu-Asp-Leu-Leu-Met-Gly-Thr-Leu-Gly-Ile-Val-Cys-Pro-Ile-Cys-Ser-Gln-Lys-Pro trifluoroacetate | 2.16.840.1.113883.3.6905.2
0‑L | 300000046063 | (3E,3aR,5S,8bS)-5-hydroxy-8,8-dimethyl-3-({[(2R)-4-methyl-5-oxo-2,5-dihydrofuran-2-yl]oxy}methylene)-3,3a,4,5,6,7,8,8b-octahydro-2H-indeno[1,2-b]furan-2-one | 2.16.840.1.113883.3.6905.2
0‑L | 300000047862 | 4-((4-((3,5-Bis(trifluoromethyl)benzyl)(5-(1-methyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)-2,6-diethylpiperidine-1-carbonyl)oxy)cyclohexane-1-carboxylic acid | 2.16.840.1.113883.3.6905.2
0‑L | 300000056616 | 52,92,96-Trichloro-85-cyclopropyl-6-oxa-2(2,5)-[1,3]benzoxazola-8(4,3)-[1,2]oxazola-5(1,4),9(1)-dibenzena-1(1)-cyclopropananonaphan-3-yne-27-carboxylic acid | 2.16.840.1.113883.3.6905.2
0‑L | 300000056697 | 6-[[16-[(6-Carboxypyridin-2-yl)methyl]-1,4,10,13-tetraoxa-7,16-diazacyclooctadec-7-yl]methyl]-4-[2-(4-isothiocyanatophenyl)ethoxy]pyridine-2-carboxylic acid | 2.16.840.1.113883.3.6905.2
0‑L | 300000056855 | Dry extract of Senna pods (5.6-6.8:1), adjusted to 12.5 mg of hydroxyanthracene glycosides, expressed as sennoside B, Extraction solvent: methanol 80% (M/M) | 2.16.840.1.113883.3.6905.2
0‑L | 100000172436 | MIXTURE OF DEPIGMENTED POLYMERIZED ALLERGEN EXTRACTS OF PHLEUM PRATENSE, FESTUCA ELATIOR, DACTYLIS GLOMERATA, LOLIUM PERENNE, POA PRATENSIS, SECALE CEREALE | 2.16.840.1.113883.3.6905.2
0‑L | 300000009248 | Multilamellar microvesicle comprising phosphatidylcholine, sphingomyelin, phosphatidylethanolamine, phosphatidylserine, phospatidylinositol and cholesterol | 2.16.840.1.113883.3.6905.2
0‑L | 300000024774 | Modified growth hormone releasing-hormone fused to the light chain endopeptidase and the N-terminal domain of the heavy chain of botulinum toxin serotype D | 2.16.840.1.113883.3.6905.2
This value set has 63646 codes in it. In order to keep the publication size manageable, only a selection (500 codes) of the whole set of codes is shown.
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavor OTH (other) suggests text in originalText. HL7 V3: NullFlavors to appear in @nullFlavor attribute instead of @code.
| XML JSON CSV SQL SVS FHIR (4.0) [xml / json]